Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | P8 - Poster Session 8

Tuesday 04/25/23
11:45 AM - 12:45 PM EST Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-oncology, Aging, Dementia, Cognitive, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG), Palliative Care, Practice, Policy, and Ethics
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM EST Abstract 9-002 - Utilizing Augmented Reality to Quantify Information Processing and Motor Performance in Military Personnel to Detect Mild Traumatic Brain Injury
Ryan Kaya, PT
11:45 AM - 12:45 PM EST Abstract 9-004 - Inter- and Intra-Rater Reliability of a Virtual Concussion Assessment During the Era of the COVID-19 Pandemic
Alani Jack
11:45 AM - 12:45 PM EST Abstract 9-005 - Evaluating Quality of Website-Derived Concussion Information
Pierce Brody
11:45 AM - 12:45 PM EST Abstract 9-006 - Increasing SUR1-related pathway activity with increasing injury severity in immune and neurovascular cells after murine TBI
Chaim T. Sneiderman
11:45 AM - 12:45 PM EST Abstract 9-007 - Delay in Clearance of Labeled Protons in Patients with Acute Head Trauma Utilizing MRI 3D TGSE PASL MRI (Arterial Spin Labeling)
Jubin Kang
11:45 AM - 12:45 PM EST Abstract 9-008 - Synthesis of Behavioral Health Outcomes in Mild Traumatic Brain Injury using Principal Component Analysis (PCA)
Teena Shetty, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 9-009 - A Systematic Review of Resting-State fMRI in Traumatic Brain Injury Across Injury Age, Severity, Mechanism, Chronicity, and Imaging Methods
Kevin Bickart, MD, PhD
11:45 AM - 12:45 PM EST Abstract 9-010 - Audit of Guidance on Contraceptive Measures and Folic Acid Supplementation in Women with Epilepsy
Emily Feeney
11:45 AM - 12:45 PM EST Abstract 9-011 - Pregnancy Seizure Outcomes for Epilepsy Patients with Catamenial Seizure Exacerbation
Paula Emanuela Voinescu, MD
11:45 AM - 12:45 PM EST Abstract 9-012 - A Look At Social Disparities in Pregnancy Outcomes in Women With Epilepsy
Jasmine Shareen Coles
11:45 AM - 12:45 PM EST Abstract 15-002 - Training Neurology Residents to Address Uncomfortable Patient Behavior Through a Simulated Experience
Sakinah Sabadia, MD
11:45 AM - 12:45 PM EST Abstract 15-003 - Teaching Neurology Trainees to Lead a Goals of Care Conversation using Simulation
Brandon Giglio, MD
11:45 AM - 12:45 PM EST Abstract 15-004 - Simulation-based Assessment of Brain Death Determination for ACGME Milestones of Adult Neurology Residents
Briana Wasserstrom, DO
11:45 AM - 12:45 PM EST Abstract 15-005 - A Telehealth Training Program for Neurology Residents
Matthew Sontag Davitz, MD
11:45 AM - 12:45 PM EST Abstract 15-006 - Resident Perceptions of a Teleneurology Curriculum
Shivika Chandra, MD
11:45 AM - 12:45 PM EST Abstract 3-001 - Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 after Re-baselining in the Phase 3 EVOLVE-MS-1 Study
James D. Bowen, MD
11:45 AM - 12:45 PM EST Abstract 3-002 - Compliance and Persistence With Ofatumumab Treatment in Patients With Relapsing Multiple Sclerosis in Clinical Trials for Up to 4 Years
Enrique Alvarez, MD, PhD
11:45 AM - 12:45 PM EST Abstract 3-003 - Remibrutinib, a Novel Bruton's Tyrosine Kinase Inhibitor, Exhibits Improved Target Selectivity and Potency In Vitro
Bernd C. Kieseier, MD
11:45 AM - 12:45 PM EST Abstract 3-004 - Five-Year Safety of Ofatumumab in People Living With Relapsing Multiple Sclerosis
Jeffrey Alan Cohen, MD
11:45 AM - 12:45 PM EST Abstract 3-005 - A systematic review and meta-analysis of extended interval dosing (EID) vs. standard-interval dosing (SID) of Natalizumab for multiple sclerosis patients.
Eslam Mohammed Rabea
11:45 AM - 12:45 PM EST Abstract 3-006 - The initial reduction in the percentage of peripheral lymphocytes and long disease course are associated with sustained response to Dimethyl Fumarate (DMF) in a small cohort of patients with Relapsing-Remitting Multiple Sclerosis
Cristina M. Ramo, MD
11:45 AM - 12:45 PM EST Abstract 3-007 - New Mitigation Protocol for Alemtuzumab Infusion Related Reactions in a Chilean Cohort
Jose Miguel Valdes Valdes, MD
11:45 AM - 12:45 PM EST Abstract 3-008 - Aspirin Precooling Improves Exercise Performance in Multiple Sclerosis: Results of a double-blind randomized controlled trial
Victoria Leavitt, PhD, FAAN
11:45 AM - 12:45 PM EST Abstract 3-009 - Ketogenic Diet Intervention Improves Sleep in Patients with Relapsing Multiple Sclerosis
Jacob Ben Perlman, MD
11:45 AM - 12:45 PM EST Abstract 3-010 - Siponimod Stabilizes Physical Disability Scores in People Living With Secondary Progressive Multiple Sclerosis After 2 Years of Treatment: Analysis From the Novartis Global Managed Access Program
Gina Mavrikis Cox, PhD
11:45 AM - 12:45 PM EST Abstract 3-011 - Ocrelizumab and Cladribine had similar EDSS stability and safety profile in patients with highly active multiple sclerosis
Fatemah Alshawaf, MD
11:45 AM - 12:45 PM EST Abstract 3-012 - Evaluating the Effect of Disease Duration in High Efficacy Versus Mid Efficacy Disease Modifying Therapies: Could This Help in Deciding When to De-escalate?
Enrique Alvarez, MD, PhD
11:45 AM - 12:45 PM EST Abstract 3-013 - AMASIA study: Real world insights on the impact of early siponimod treatment on SPMS patients in Germany
Olaf Hoffmann, MD
11:45 AM - 12:45 PM EST Abstract 3-014 - Safety and efficacy of Cladribine in real life sitting, Kuwait Experience
Malak AlMojel, MD
11:45 AM - 12:45 PM EST Abstract 3-015 - Efficacy and Safety Profile of Cladribine Tablets in an Italian Real-Life Cohort of Relapsing-Remitting Multiple Sclerosis Patients: A Monocentric Longitudinal Observational Study
Paolo Preziosa
11:45 AM - 12:45 PM EST Abstract 3-016 - Progressive Multifocal Leukoencephalopathy (PML) With Anti-CD20 and Other Monoclonal Antibody (mAb) Therapies in Multiple Sclerosis
Kanika Sharma
11:45 AM - 12:45 PM EST Abstract 3-017 - Male MS Patients' Safety, Tolerability and Efficacy Outcomes Do Not Differ from Female Patients Treated with Diroximel Fumarate: EVOLVE-MS-1 Ad-hoc Analysis
Annette Wundes, MD
11:45 AM - 12:45 PM EST Abstract 3-018 - A Case Report: Simultaneous Presentation of Morphea and Multiple Sclerosis, a Diagnostic and Management Challenge.
Richa Mehta Thakkar, DO
11:45 AM - 12:45 PM EST Abstract 12-001 - Identifying Neuroimaging Patterns in Mitochondrial Leukoencephalopathies
Sonal Sharma, MD
11:45 AM - 12:45 PM EST Abstract 12-002 - Generative Editing via Convolutional Obscuring (GECO): A Generative Adversarial Network for MRI de-artifacting
Bryce Allen Bagley
11:45 AM - 12:45 PM EST Abstract 12-003 - Radiological features of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and its longitudinal progression
Rajasimhan Rajagovindan, PhD
11:45 AM - 12:45 PM EST Abstract 12-004 - A Multimodal Neuroimaging Feature Extraction Framework for Biomarker Discovery in Myotonic Dystrophies
Tahereh Kamali
11:45 AM - 12:45 PM EST Abstract 12-005 - A Case Report on the Elusivity of Imaging in Detecting a Ruptured Dermoid Cyst
Simerun Singh, MD
11:45 AM - 12:45 PM EST Abstract 12-006 - Neuroimaging in Acute Ethylene Glycol Toxicity
James Christian Hiana, MD
11:45 AM - 12:45 PM EST Abstract 12-007 - Diabetic Striatopathy; A Differential Worth Considering in Diabetic Patients with Acute Onset Hyperkinetic Movements or Basal Ganglia (Striatal) Abnormalities on Imaging.
Samuel Durojaye, MD
11:45 AM - 12:45 PM EST Abstract 6-001 - Lack of Better Functional Outcomes in Young Border Hispanic Patients with Acute Ischemic Stroke after Endovascular Thrombectomy Compared to Older Patients: A Retrospective Chart Review
Saisree Ravi
11:45 AM - 12:45 PM EST Abstract 6-002 - Optimizing Management and Outcomes of Large Vessel Occlusion Ischemic Stroke Utilizing Mobile Stroke Units
Muhammad Bilal Tariq, MBBS
11:45 AM - 12:45 PM EST Abstract 6-004 - The BAND score: a simple upfront predictive model for futile recanalization to guide patient selection for endovascular thrombectomy during acute ischemic stroke triage
Huanwen Chen, MD
11:45 AM - 12:45 PM EST Abstract 6-005 - Tenecteplase Versus Alteplase for Acute Ischemic Stroke in a Community Hospital Setting
Latha Ganti, MD, MS, MBA, FACEP
11:45 AM - 12:45 PM EST Abstract 6-006 - Patterns in the Number of Interventionalists for Endovascular Treatment of Acute Ischemic Stroke in the US
Ankita Tripathi, MD
11:45 AM - 12:45 PM EST Abstract 6-008 - Intra-Arterial Thrombolysis Associated with Symptomatic Intracranial Hemorrhage in Acute Basilar Artery Thrombectomy, PC-SEARCH Registry Analysis
Adam T. Mierzwa, MD
11:45 AM - 12:45 PM EST Abstract 6-009 - Stenting Plus Medical Therapy versus Medical Therapy Alone in Patients With Symptomatic Intracranial Stenosis: A Systematic Review and Meta-Analysis
Artur Menegaz de Almeida
11:45 AM - 12:45 PM EST Abstract 6-010 - Real World Experience with Viz.ai Automated Large Vessel Occlusion in CT Angiogram
Nick Mannix, MD
11:45 AM - 12:45 PM EST Abstract 6-011 - Improving Thrombectomy Times Utilizing Stroke Transfer Coordinators
Jessica Doyle Lee, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 6-012 - Predictors of Functional Recovery after Mechanical Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation
Milagros Galecio-Castillo, MD
11:45 AM - 12:45 PM EST Abstract 6-013 - Quality and Outcomes Following Implementation of Anesthesiology for all Mechanical Thrombectomy Cases
Madison McGann
11:45 AM - 12:45 PM EST Abstract 6-014 - Pre-morbid Risk Factor Control Differences by Age in Patients Undergoing Thrombectomy for Acute Ischemic Stroke
Kathryn Margaret Grimes, MD
11:45 AM - 12:45 PM EST Abstract 6-015 - Acute Ischemic Stroke Large Vessel Occlusion treated with Mechanical Thrombectomy in the Pediatric Populatio
Jessica Glenn, NP
11:45 AM - 12:45 PM EST Abstract 6-016 - Acute loading dose of antiplanets before Stent-assisted repair of cerebral aneurysm associated with reduced ischemic events and good outcomes
Yahia M. Lodi, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 6-017 - Intravenous Thrombolysis followed by Endovascular Thrombectomy compared with Direct Endovascular Thrombectomy for Stroke: a Systematic Review and Meta-analysis of Randomized and Non-Randomized Studies
Bakhtawar Ahmad, MBBS
11:45 AM - 12:45 PM EST Abstract 6-018 - Comparison of Tele-stroke transfer between intervention and non-intervention cases and 30-day outcome events
Shravan Sivakumar, MBBS
11:45 AM - 12:45 PM EST Abstract 6-019 - Area Deprivation Index (ADI) and Median Income Associations with Clinical Outcomes of Endovascular Therapy for ACLVO stroke
Murat Sari, MD
11:45 AM - 12:45 PM EST Abstract 6-020 - Indications and Outcomes of Carotid Artery Stenting among Consecutive Patients over Age 70 at The Ottawa Hospital, a Comprehensive Stroke Centre in Ontario, Canada
Holly Sim, MD
11:45 AM - 12:45 PM EST Abstract 6-021 - Effect of Stroke Etiology on Mechanical Thrombectomy Outcomes in Young Adults: A Retrospective Data Analysis
Kriti Bhayana, MD
11:45 AM - 12:45 PM EST Abstract 6-022 - Examining Predictors of Favorable 90-day Outcome in Stroke Patients with Active Cancer Undergoing Endovascular Therapy
Yasaman Pirahanchi, MD
11:45 AM - 12:45 PM EST Abstract 6-023 - Osteoarthritis is associated with lower likelihood of receiving stroke thrombectomy despite similar post-thrombectomy outcomes: a national study
Huanwen Chen, MD
11:45 AM - 12:45 PM EST Abstract 6-024 - Onyx© Embolization of Dural Arteriovenous Fistulae at the Cranio-Cervical Junction
Khaled Gharaibeh, MD
11:45 AM - 12:45 PM EST Abstract 6-025 - Lack of Pre-treatment Thrombolysis and Low ASPECTS are Associated with Poor Rates of Recanalization After Mechanical Thrombectomy
Muhammad M. Alvi, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 6-026 - Bilateral Middle Meningeal Artery Embolization and Resection of a Large Parafalcine Meningioma: a Case Study
Melinda Christine Arthur, DO
11:45 AM - 12:45 PM EST Abstract 6-027 - Successful Prevention of Bow Hunter's Stroke Associated with Rheumatoid Atlantoaxial Subluxation via Coil Occlusion
Ryoichi Inoue, MD
11:45 AM - 12:45 PM EST Abstract 6-028 - Recanalized paramedian thalamoperforators after intraarterial tirofiban treatment in a patient with bilateral fetal-type PCAs
Minyoul Baik, Jr., MD
11:45 AM - 12:45 PM EST Abstract 6-029 - Large Vessel Occlusion Related Ischemic Stroke From Vitamin B12-Deficiency Related Homocysteine
Shruthi Harish, MBBS
11:45 AM - 12:45 PM EST Abstract 6-030 - Anterior Cerebral Artery Associated “Limb-Shaking TIA” A3 Branch Stenosis Corrected With Submaximal Intracranial Angioplasty
Kholoud Yaser Altarazi, MD
11:45 AM - 12:45 PM EST Abstract 6-031 - Foreign Body Reaction After Endovascular Treatment with Pipeline Embolization Device
Ma Su Su Aung, MD
11:45 AM - 12:45 PM EST Abstract 7-001 - Amyotrophic Lateral Sclerosis and Aid-in-Dying: Describing and Comparing ALS Patients Requesting Physician-Assisted Death with Patients Dying Directly of ALS in the Hospital Setting
Pierre Trudel
11:45 AM - 12:45 PM EST Abstract 7-002 - Simulation training in Neuropalliative Care
Rakhee Lalla, DO
11:45 AM - 12:45 PM EST Abstract 7-003 - Palliative and end-of-life care in Parkinson’s disease : a survey of patients’ perceptions and knowledge in France
Manon Auffret, PhD, PharmD
11:45 AM - 12:45 PM EST Abstract 7-004 - Are Neurologists Aware of the Neurology-Specific Hospice Criteria?
Daniel Minsuk Oh, MD
11:45 AM - 12:45 PM EST Abstract 7-005 - Palliative Care Knowledge and Attitudes among Patients with Neurodemyelinating Diseases
Aliza Ben-Zacharia, PhD, DNP, ANP
11:45 AM - 12:45 PM EST Abstract 7-006 - Outpatient Palliative Care for Parkinson’s Disease: Results from a National Survey
Kei Sugiura, MD
11:45 AM - 12:45 PM EST Abstract 7-007 - Clinical Outcomes From a Phase 2, Open-Label Study of NE3107 in Patients With Cognitive Decline Due to Degenerative Dementias
Kaya Gloyd Jordan, CRC
11:45 AM - 12:45 PM EST Abstract 7-008 - Allopregnanolone as a Regenerative Therapeutic for Alzheimer’s Disease (AD): A phase 2 proof-of-concept clinical trial using hippocampal volume as a surrogate endpoint
Gerson David Hernandez Rivera, MD, MPH
11:45 AM - 12:45 PM EST Abstract 7-009 - A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Donepezil Transdermal Delivery System
Alan Blau, PhD
11:45 AM - 12:45 PM EST Abstract 7-010 - A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Effects of SAGE-718 in Patients with Alzheimer's Disease: Study Design
Tiffany Lago, MD
11:45 AM - 12:45 PM EST Abstract 1-001 - EEG Characteristics of Mortality in Patients with Altered Mental Status and Seizures: A Matched Case-Control Study
Rizk Alghorazi
11:45 AM - 12:45 PM EST Abstract 1-002 - Anti-seizure Medication Use and Outcomes in Older Adults with Acute Traumatic Brain Injury
Poojith Nuthalapati
11:45 AM - 12:45 PM EST Abstract 1-003 - The Utilization of the Ketogenic Diet for Adults with Status Epilepticus
Fernanda Jacinto Pereira Teixeira, MD
11:45 AM - 12:45 PM EST Abstract 1-004 - A Modern Artillery to put off the Electric Storm of the Brain– A case report of aborting seizure with brivaracetam 2-minute intravenous bolus in a patient with a compromised airway.
Maycky Tang, DO
11:45 AM - 12:45 PM EST Abstract 1-005 - High-Dose Levetiracetam: A Novel Post-Arrest Anti-Arrhythmic Medication?
Eric Stulberg, MD
11:45 AM - 12:45 PM EST Abstract 1-006 - Evaluating Barriers and Tools to Optimize Resident Call Scheduling on Neurology In-Patient Services
James Joon Hyuck Im, MD
11:45 AM - 12:45 PM EST Abstract 10-001 - Is ALS Onset Accelerated by Chloroviruses and Delayed by Antiviral Immune Responses?
Gary L. Pattee, MD
11:45 AM - 12:45 PM EST Abstract 10-002 - ALS Causative Mutations in KIF5A Disrupt Autoinhibition Leading to Toxic Gain of Function
Jonathan R. Brent, MD, PhD
11:45 AM - 12:45 PM EST Abstract 10-003 - At-Home Telespirometry [AHT] in Amyotrophic Lateral Sclerosis [ALS]
Eufrosina I. Young, MD
11:45 AM - 12:45 PM EST Abstract 10-004 - Evidence for Survival Benefit in ALS with CNM-Au8 Treatment Across Three Study Populations
James D. Berry, MD MPH
11:45 AM - 12:45 PM EST Abstract 10-005 - Quantification of HLA Allele and Haplotype Frequencies in ALS and ALS-FTD
Darshan Pandya, MD
11:45 AM - 12:45 PM EST Abstract 10-006 - The role of systemic immunity in ALS: a population-based study
Maurizio Grassano, MD
11:45 AM - 12:45 PM EST Abstract 10-007 - Small Molecule Positive Modulator of Hepatocyte Growth Factor (HGF)/MET, ATH-1105, Improves Function and Reduces Disease Biomarkers in a TDP-43 Mouse Model of Amyotrophic Lateral Sclerosis
Jewel Johnston
11:45 AM - 12:45 PM EST Abstract 10-008 - Objective Measures of Gait Changes in ALS Correlate with Functional Rating Scale
Marcell Paul Szabo
11:45 AM - 12:45 PM EST Abstract 10-009 - At-Home Telespirometry (AHT) In ALS Implementation Science: Different Patient Rates of Erect Forced Vital Capacity (eFVC) 3 percent predicted (%p) Drops per Month in Two ALS Populations with Different Baseline Rates of NIV Utilization
Benjamin R. Brooks, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 10-010 - The Integrated Stress Response Is Modulated by eIF2B Agonist DNL343: Results From Phase 1 Healthy Subject and Phase 1b ALS Patient Studies.
Linus D Sun, MD, PhD
11:45 AM - 12:45 PM EST Abstract 10-011 - A 40-week Phase 2B Randomized, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Memantine in Amyotrophic Lateral Sclerosis
Salman Bhai, MD
11:45 AM - 12:45 PM EST Abstract 10-013 - MicroRNA Expression in ALS: A Systematic Review and Bioinformatic Analysis
María Paula Aguilera Peña, MD
11:45 AM - 12:45 PM EST Abstract 10-014 - Introduction of Quantitative Scale for Fasciculations in ALS Patients
Cecilia Quarracino Benchetrit, MD
11:45 AM - 12:45 PM EST Abstract 10-015 - Seronegative Isaac Syndrome Presenting as Focal Limb Stiffness Responsive to Plasma Exchange Therapy
Nadia Khalil, MD
11:45 AM - 12:45 PM EST Abstract 4-001 - Sex and Gender Differences Influence Urinary Symptoms and Management in Multiple System Atrophy
Elke Schipani Bailey, MD
11:45 AM - 12:45 PM EST Abstract 4-002 - Wearable Sensors for Quantitative Motor Assessments in Multiple System Atrophy
Daniel O. Claassen, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 4-003 - Patient Concept Elicitation Interviews: Insights into Multiple System Atrophy (MSA) Patient Experiences and Relevance of a modified United Multiple System Atrophy Rating Scale
Michele Potashman, PhD
11:45 AM - 12:45 PM EST Abstract 4-004 - Application of Phosphorylated Alpha Synuclein (p-syn) Skin Biopsy in Clinical Practice: Audit at an Academic Medical Center
Cheng Chin Wang, DO
11:45 AM - 12:45 PM EST Abstract 4-005 - Dysautonomia symptoms and quality of life in non-hospitalized neurology outpatients with post-acute sequelae of COVID-19
Samarah Ahmed
11:45 AM - 12:45 PM EST Abstract 4-006 - A Case of Autonomic Failure in Superficial Siderosis
Bridget Ollesch, MD
11:45 AM - 12:45 PM EST Abstract 4-007 - Peripheral sudomotor abnormalities in postural tachycardia syndrome (POTS)
Anna Newman
11:45 AM - 12:45 PM EST Abstract 4-008 - Botulinum toxin for Sialorrhea in Patients with Parkinson’s disease & Atypical Parkinsonism: A Single Center Real-World Study
Danyaal Buttar
11:45 AM - 12:45 PM EST Abstract 4-009 - Adverse Childhood Experiences Are Associated with Seizures in Children: A Cross-Sectional Analysis
Marissa Anto, MD
11:45 AM - 12:45 PM EST Abstract 4-010 - Distinguishing TLE and TLE+ using magnetoencephalography virtual sensors
Joanna Hong
11:45 AM - 12:45 PM EST Abstract 4-011 - PRAX-562-101: A Phase 1 Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of PRAX-562 in Healthy Volunteers
Brian Pfister
11:45 AM - 12:45 PM EST Abstract 4-012 - PRAX-628: A Novel Sodium Channel Blocker with Greater Potency and Activity Dependence Compared to Standard of Care
Kris Kahlig, PhD
11:45 AM - 12:45 PM EST Abstract 13-001 - Adult-Onset Acute Flaccid Myelitis with White Matter-predominant Longitudinally Extensive Transverse Myelitis Following Coxsackie B5 Enterovirus Infection: a case report
Olga Manouvakhova, MD
11:45 AM - 12:45 PM EST Abstract 13-002 - A Case Report of Parainfectious Opsoclonus-Myoclonus Syndrome after Powassan Virus Meningitis
Stephanie Bridget Syc-Mazurek, MD, PhD
11:45 AM - 12:45 PM EST Abstract 13-003 - Subacute Development of Parkinsonism as a Clinical Manifestation of Powassan Virus Neuroinvasive Disease
Clifton Lewis, DO
11:45 AM - 12:45 PM EST Abstract 13-004 - Concomitant West Nile Virus Encephalitis and Ischemic Strokes – A Case Report and Review of the Literature.
Karan Hingorani, MD, PhD
11:45 AM - 12:45 PM EST Abstract 13-005 - A Retrospective Review on Encephalitis in the University of Colorado Health Care System and a Proposed Diagnostic Approach
Madeline Garza, MD
11:45 AM - 12:45 PM EST Abstract 13-006 - What’s the Cure for These Hiccups?: A Case of Area Postrema Syndrome due to Ventriculitis
Audrey Wadood, MD
11:45 AM - 12:45 PM EST Abstract 13-007 - A Case of Blood Culture-Negative Infective Endocarditis Presenting as Recurrent Ischemic Stroke
Sydney Chatfield
11:45 AM - 12:45 PM EST Abstract 5-001 - Perry syndrome – the genetic, clinical, and pathological characteristics of the disease
Jaroslaw Dulski
11:45 AM - 12:45 PM EST Abstract 5-002 - Rate of Change of Pons and Middle Cerebellar Peduncle Diameters is Diagnostic of Multiple System Atrophy of the Cerebellar Type (MSA-C)
Christopher D. Stephen, MB ChB FRCP SM
11:45 AM - 12:45 PM EST Abstract 5-003 - Sex Differences for Verbal Fluency Decline in Progressive Supranuclear Palsy
Leonardino Digma, MD
11:45 AM - 12:45 PM EST Abstract 5-004 - Effect of APOE e4 genotype on age at onset and comorbid pathologies in multiple system atrophy
Hiroaki Sekiya, MD, PhD
11:45 AM - 12:45 PM EST Abstract 5-005 - Characteristics and Outcome of Patients with Young-Onset Multiple System Atrophy
Negin Badihian, MD
11:45 AM - 12:45 PM EST Abstract 5-006 - Predictors of Survival in Atypical Parkinsonian Syndromes in a Tunisian Cohort
Amina Nasri, MD
11:45 AM - 12:45 PM EST Abstract 5-007 - Longitudinal free-water changes in dementia with Lewy bodies
Shannon Chiu, MD
11:45 AM - 12:45 PM EST Abstract 5-009 - Retrospective Review of Amantadine Use in Progressive Supranuclear Palsy
Nikolaus McFarland, MD, PhD, FAAN
11:45 AM - 12:45 PM EST Abstract 5-010 - Who Should Answer? How to Assess Psychosis in Demented Patients with Parkinson’s Disease or Lewy Body Dementia.
Blake Beehler, MD
11:45 AM - 12:45 PM EST Abstract 5-011 - Efficacy of Omaveloxolone in Friedreich’s Ataxia: Post-Hoc Analysis Using Global Statistics Test to Strengthen Secondary Endpoint Analyses
Suzanne Hendrix, PhD
11:45 AM - 12:45 PM EST Abstract 5-012 - Somatosensory evoked potentials in spinocerebellar ataxias type 3 and 10: Preliminary data
Leo Coutinho, MD
11:45 AM - 12:45 PM EST Abstract 5-013 - Anti-Ma2 Antibody Paraneoplastic Cerebellar Degeneration Associated with Renal Cell Carcinoma: A Case Report.
Nada Ahmed, MD
11:45 AM - 12:45 PM EST Abstract 5-014 - Cala Trio wrist-worn medical device for tremor improvement in patient with Spinocerebellar Ataxia-12
Syed Mehdi Husaini
11:45 AM - 12:45 PM EST Abstract 5-015 - Intrafamilial Heterogeneity in Spinocerebellar Ataxia Type 21
Emma Limehouse Wetmore
11:45 AM - 12:45 PM EST Abstract 5-016 - Rapidly Progressive Cerebellar Ataxia and Dementia due to Cortical Cerebellar and Thalamic Degeneration: A Case Series of Two Autopsy Confirmed Patients
Shunsuke Koga, MD, PhD
11:45 AM - 12:45 PM EST Abstract 5-017 - Subgroup Analyses of Effect of Treatment With Levodopa Inhalation Powder (CVT-301) 84mg by Severity of OFF Symptoms in People with Parkinson’s Disease, as Assessed by the Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III)
Ron Cohen, MD
11:45 AM - 12:45 PM EST Abstract 2-001 - Impact of Updates in Headache Quality Measures on Adherence to Best Practices in a Neurology Resident Clinic
Robert Hemant Cascella
11:45 AM - 12:45 PM EST Abstract 2-002 - A Machine Learning Model Including Questionnaire and Structural Imaging Data Predicts Headache Improvement in Patients with Acute Post-traumatic Headache Attributed to Mild Traumatic Brain Injury
Catherine Daniela Chong, PhD, FAAN
11:45 AM - 12:45 PM EST Abstract 2-003 - Development and validation of a novel model for characterizing migraine outcomes within electronic health records utilizing artificial intelligence
Carlton Anderson, PhD
11:45 AM - 12:45 PM EST Abstract 2-004 - Brain volume changes associated with the recurrence of spontaneous intracranial hypotension after epidural blood patch
Sun Ju Chung, MD, PhD, FAAN
11:45 AM - 12:45 PM EST Abstract 2-005 - Clinician Perspectives on Remote Monitoring for Patients with Headache Disorders
Aarti Raj Katara
11:45 AM - 12:45 PM EST Abstract 2-006 - Asynchronous Telemedicine Platform Associated with Decreased Migraine-Related Emergency Room and Urgent Care Use
Sara C. Crystal, MD
11:45 AM - 12:45 PM EST Abstract 2-007 - Psychometric Evaluation of the Migraine-Specific Quality of Life Questionnaire (MSQ v2.1) Using Data From Phase 3 Clinical Trials in Patients With Chronic Migraine (CM) and Episodic Migraine (EM)
Krutika Jariwala-Parikh, PhD
11:45 AM - 12:45 PM EST Abstract 2-008 - Psychometric Evaluation of the Activity Impairment in Migraine-Diary (AIM-D) Using Data From a Phase 3 (PROGRESS) Clinical Trial in Patients With Chronic Migraine
Krutika Jariwala-Parikh, PhD
11:45 AM - 12:45 PM EST Abstract 2-009 - A Telemedicine Platform to Increase Access to Migraine Care in Men
Sara C. Crystal, MD
11:45 AM - 12:45 PM EST Abstract 2-010 - Patient-identified most bothersome symptom as a driver of health-related quality of life experienced by patients with migraine
Peter Goadsby, MD, PhD, FRS
11:45 AM - 12:45 PM EST Abstract 2-011 - CME-Certified Microlearning Platform Successful in Improving Knowledge on the Use of Preventive Migraine Therapies Among Neurologists and PCPs
Thomas Finnegan, Jr., PhD
11:45 AM - 12:45 PM EST Abstract 2-012 - Circulating microRNAs in migraine patients: Systematic review and bioinformatic analysis.
María Paula Aguilera Peña, MD
11:45 AM - 12:45 PM EST Abstract 11-001 - Economic Impact of a Multidisciplinary Neurofibromatosis Clinic in a Canadian Tertiary Care Hospital
Julien Rousseau, MD,CM
11:45 AM - 12:45 PM EST Abstract 11-003 - Growth of Angiomyolipomas in Patients with Tuberous Sclerosis Complex Treated with mTOR Inhibitor Differs by Indication for Treatment
Lauren Alexandra Neal
11:45 AM - 12:45 PM EST Abstract 11-004 - Identifying Lesions of the Corpus Callosum in Patients with Neurofibromatosis Type I
Nora Rani Jandhyala
Faculty Disclosures
Jonathon Jonas Lebovitz Dr. Lebovitz has stock in Vesalio.
Hailu Chen Hailu Chen has received personal compensation for serving as an employee of Biogen.com. Hailu Chen has received stock or an ownership interest from Biogen.com.
Ramsha Farrukh, MD Dr. Farrukh has nothing to disclose.
Lesley Ann Kane, PhD Dr. Kane has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Kane has stock in Denali Therapeutics.
Scott D. Eggers, MD Dr. Eggers has received intellectual property interests from a discovery or technology relating to health care. Dr. Eggers has received publishing royalties from a publication relating to health care.
Perrin A. Pleninger, MD, FAAN Dr. Pleninger has nothing to disclose.
Alya Gharbi Alya GHARBI has nothing to disclose.
Kelsey M. Owen Ms. Owen has nothing to disclose.
Shanshan Chen, PhD Dr. Chen has nothing to disclose.
Sujata P. Thawani, MD Dr. Thawani has nothing to disclose.
Paola Sandroni, MD, PhD, FAAN Dr. Sandroni has nothing to disclose.
Carolina B. Maciel, MD, MSCR, FAAN Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health.
Guillaume Lamotte, MD Dr. Lamotte has nothing to disclose.
Kavita Nair, PhD, FAAN Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Healthcare. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS.
John Corboy, MD, FAAN Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Alexandra L. Czap, MD The institution of Dr. Czap has received research support from SVIN. The institution of Dr. Czap has received research support from AAN.
Ariane Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Negin Badihian, MD Dr. Badihian has nothing to disclose.
Merit E. Cudkowicz, MD, MSC, FAAN Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for denali. The institution of Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for wave. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurosense. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for Arrowhead. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eledon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . An immediate family member of Dr. Cudkowicz has stock in Sqz. The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSA . The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Anna Marisa Cervantes-Arslanian, MD, FAAN Dr. Cervantes-Arslanian has nothing to disclose.
James Nick Brenton, MD Dr. Brenton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharmaceuticals. The institution of Dr. Brenton has received research support from NIH/NINDS. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Expert Interview with MDEdge. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH.
Hoang Nhu Nguyen Ms. Nguyen has received personal compensation for serving as an employee of DENALI THERAPEUTICS. Ms. Nguyen has stock in Denali Therapeutics.
Jennifer Lauren Orthmann Murphy, MD, PhD Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for Vigil Neuroscience. Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoGlia. The institution of Dr. Orthmann Murphy has received research support from Vigil Neurosciences. The institution of Dr. Orthmann Murphy has received research support from National MS Society. The institution of Dr. Orthmann Murphy has received research support from Fishman Family Foundation. The institution of Dr. Orthmann Murphy has received research support from Global Leukodystrophy Initiative Clinical Trial Network. Dr. Orthmann Murphy has received personal compensation in the range of $500-$4,999 for serving as a Developing CME content on Neurogenetics with American Neurological Association.
Maycky Tang, DO Dr. Tang has nothing to disclose.
Heather Gelhorn, PhD Dr. Gelhorn has stock in ThermoFisher Scientific. Dr. Gelhorn has stock in PPD.
Mackenzie Cervenka, MD Dr. Cervenka has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nutricia. Dr. Cervenka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle Health Science/Vitaflo. The institution of Dr. Cervenka has received research support from Nestle Health Science/Vitaflo. Dr. Cervenka has received publishing royalties from a publication relating to health care.
Taryn Haselhuhn, NP Mrs. Haselhuhn has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DKBmed.
Brandi L. Vollmer, MPH Ms. Vollmer has nothing to disclose.
Stefan Sillau The institution of Stefan Sillau has received research support from Alzheimer's Association. The institution of Stefan Sillau has received research support from Hewitt Family Foundation; State of Colorado. The institution of Stefan Sillau has received research support from PCORI. The institution of Stefan Sillau has received research support from NINR. The institution of Stefan Sillau has received research support from Michael J. Fox Foundation. The institution of Stefan Sillau has received research support from Department of Defense. The institution of Stefan Sillau has received research support from Colorado Department of Public Health and Environment. The institution of Stefan Sillau has received research support from Benign Essential Blepharospasm Research Foundation. Stefan Sillau has a non-compensated relationship as a Statistician with Novartis that is relevant to AAN interests or activities. Stefan Sillau has a non-compensated relationship as a Statistician with Biogen that is relevant to AAN interests or activities.
Devin Nikjou Mr. Nikjou has nothing to disclose.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Kimberly Scearce-Levie Kimberly Scearce-Levie has received personal compensation for serving as an employee of Denali Therapeutics. Kimberly Scearce-Levie has stock in Denali Therapeutics.
Girardin Jean-Louis No disclosure on file
Neil Parikh, MD Dr. Parikh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thirty Madison.
Jacinda B. Sampson, MD, PhD Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Jinsy Andrews, MD, FAAN Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revalasio . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Biohaven/Platform Trial. The institution of Dr. Andrews has received research support from Clene/Platform Trial . The institution of Dr. Andrews has received research support from Ra Pharma/Platform Trial . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . Dr. Andrews has received research support from ALS Association . Dr. Andrews has a non-compensated relationship as a Board of Trustee Member with ALS Association that is relevant to AAN interests or activities. Dr. Andrews has a non-compensated relationship as a Co-Chair with Northeast ALS (NEALS) Consortium that is relevant to AAN interests or activities.
Christopher Goetz, MD, FAAN The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Arielle Marisa Kurzweil, MD, FAAN Dr. Kurzweil has nothing to disclose.
Aaron Eduardo Rodriguez-Calienes Dr. Rodriguez-Calienes has nothing to disclose.
Alicia Zha, MD Dr. Zha has nothing to disclose.
Mustafa Al-Chalabi, DO Dr. Al-Chalabi has nothing to disclose.
Nada Hisham Mahmoud Dr. Mahmoud has nothing to disclose.
Hamzah Selim Mr. Selim has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Mindstep . Mr. Selim has stock in Mindstep.
Lauren Alexandra Neal Miss Neal has nothing to disclose.
Jessica Glenn, NP Mrs. Glenn has nothing to disclose.
Laura Stein, MD The institution of Dr. Stein has received research support from American Heart Association.
Ashutosh P. Jadhav, MD, FAAN Dr. Jadhav has nothing to disclose.
Jan Claassen, MD, PhD Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Hernan Nicolas Lemus Esquivel, MD Dr. Lemus Esquivel has nothing to disclose.
Milagros Galecio-Castillo, MD Dr. Galecio-Castillo has nothing to disclose.
Anne Marie Morse, DO,Other The institution of Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals, Harmony Biosciences, Avadel Pharmaceuticals, Takeda Pharmaceuticals, Alkermes, National Institute for Health, and Geisinger Health Plan. The institution of Dr. Morse has received research support from Harmony Biosciences, Avadel Pharmaceuticals, Takeda Pharmaceuticals, Alkermes, National Institute for Health, and Geisinger Health Plan.
James Joon Hyuck Im, MD Dr. Im has nothing to disclose.
Kejal Kantarci, MD The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF.
Naomi Sara Lebowitz, Other Ms. Lebowitz has nothing to disclose.
Simran Mehrotra Miss Mehrotra has nothing to disclose.
Rizk Alghorazi Mr. Alghorazi has nothing to disclose.
Venka Veerappan, MD Dr. Veerappan has nothing to disclose.
Sai L. Shankar, PhD, FAAN Dr. Shankar has received personal compensation for serving as an employee of Biogen. Dr. Shankar has stock in Biogen.
Alexis George Ms. George has nothing to disclose.
Tomoaki Miyake, MD Mr. Miyake has nothing to disclose.
Vivien H. Lee, MD, FAAN Dr. Lee has nothing to disclose.
Roy E. Strowd, III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Mihir Kakara, MD Dr. Kakara has nothing to disclose.
Thanh Ngoc Nguyen, MD Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vesalio. Dr. Nguyen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avania. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Nguyen has received research support from Boston Medical Center. The institution of Dr. Nguyen has received research support from Society of Vascular and Interventional Neurology.
Soojin Park, MD Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health.
Christina Wilson, MD, FAAN The institution of an immediate family member of Dr. Wilson has received research support from NIH. An immediate family member of Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care.
Nick Mannix, MD Dr. Mannix has nothing to disclose.
Maryna Skliut, MD Dr. Skliut has nothing to disclose.
Katherine Ross Katherine Ross has nothing to disclose.
Yukihiro Yamao, MD,PhD Dr. Yamao has nothing to disclose.
Marissa Anto, MD Dr. Anto has nothing to disclose.
Colin Waltz, Other Mr. Waltz has nothing to disclose.
Kevin Church, PhD Dr. Church has received personal compensation for serving as an employee of Athira Pharma. Dr. Church has stock in Athira Pharma. Dr. Church has received intellectual property interests from a discovery or technology relating to health care.
Jeremy Chaufty, PhD Mr. Chaufty has received personal compensation for serving as an employee of UCB. Mr. Chaufty has stock in UCB. Mr. Chaufty has received intellectual property interests from a discovery or technology relating to health care.
Ahmed Esmael, PhD Dr. Esmael has nothing to disclose.
Jewel Johnston Dr. Johnston has received personal compensation for serving as an employee of Athira Pharma, Inc. Dr. Johnston has stock in Athira Pharma, Inc. An immediate family member of Dr. Johnston has stock in Athira Pharma, Inc. Dr. Johnston has received intellectual property interests from a discovery or technology relating to health care.
Meng Fang Dr. Fang has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Fang has stock in Denali therapeutics.
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli-Lilly. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tremeau. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddys. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon Biopharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from Celgene. The institution of Dr. Goadsby has received research support from NIHR. The institution of Dr. Goadsby has received research support from Kallyope. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Executive roles with American Headache Society that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Director with American Migraine Foundation that is relevant to AAN interests or activities.
Irene Litvan, MD, FAAN Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Katharina M. Busl, MD, MS, FAAN Dr. Busl has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. The institution of Dr. Busl has received research support from University of Florida Self Insurance Program. The institution of Dr. Busl has received research support from National Institutes of Health. Dr. Busl has a non-compensated relationship as a Board Member with Art in Medicine that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Associate Editor with Critical Care Explorations that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Editorial Board Member with Neurocritical Care that is relevant to AAN interests or activities.
Michel Toledano, MD Dr. Toledano has nothing to disclose.
Kathleen B. Digre, MD, FAAN Dr. Digre has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Headache Society. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuro-ophthalmology. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Utah Womens Health Review. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care.
Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for eNova. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. The institution of Dr. Moura has received research support from NIH-NIA - 1K08AG053380-01A1. The institution of Dr. Moura has received research support from NIH-NIA 5R01AG062282-02 . The institution of Dr. Moura has received research support from NIH-NIA 2P01AG032952-11 . The institution of Dr. Moura has received research support from NIH- NIA 3R01AG062282-03S1 . The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America .
Nikolaus McFarland, MD, PhD, FAAN Dr. McFarland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sutter Health. The institution of Dr. McFarland has received research support from NIH. Dr. McFarland has received publishing royalties from a publication relating to health care.
K. H. Vincent Lau, MD Dr. Lau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. The institution of Dr. Lau has received research support from Amyloidosis Foundation.
Stephanie Bridget Syc-Mazurek, MD, PhD An immediate family member of Dr. Syc-Mazurek has received personal compensation for serving as an employee of Delos Living .
Nora Rani Jandhyala Ms. Jandhyala has nothing to disclose.
Jennifer Axelband, DO Dr. Axelband has nothing to disclose.
Andrea J. Bartels, NP Ms. Bartels has nothing to disclose.
Salman Sani, MBBS Dr. Sani has nothing to disclose.
Sara C. Crystal, MD Dr. Crystal has received personal compensation for serving as an employee of Thirty Madison. Dr. Crystal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Crystal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Ahmad Muhammad Awd Almelegy, MD Dr. Almelegy has nothing to disclose.
Wassilios Meissner Wassilios Meissner has received personal compensation in the range of $0-$499 for serving as a Consultant for Biohaven. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alterity. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inhibikase. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Wassilios Meissner has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Hiba Afroze Saleem Miss A Saleem has nothing to disclose.
Claudia Lopez Mrs. Lopez has nothing to disclose.
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Mohammad Mahmud, FRACP, RN Mr. Mahmud has received personal compensation for serving as an employee of Mindset Technologies Ltd .
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from GE Healthcare. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Amanda Lee Piquet, MD, FAAN The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Novartis. The institution of Dr. Piquet has received research support from Abbvie. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Meeryo Choe, MD, FAAN Dr. Choe has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Cases. The institution of Dr. Choe has received research support from NIH. The institution of Dr. Choe has received research support from AIR-P. Dr. Choe has a non-compensated relationship as a Board of Directors with NABIS that is relevant to AAN interests or activities. Dr. Choe has a non-compensated relationship as a Consultant with USA Swimming Concussion Task Force that is relevant to AAN interests or activities.
Seemant Chaturvedi, MD, FAAN, FAHA Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Calgary. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ramar & Paradiso. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cole, Scott, Kissane. The institution of Dr. Chaturvedi has received research support from NINDS.
Avindra Nath, MD, MBBS, FAAN Dr. Nath has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from ALS Association. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Paula Emanuela Voinescu, MD The institution of Dr. Voinescu has received research support from NIH. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Neurodiem. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Physicians' Education Resouce. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Epilepsy Society. Dr. Voinescu has a non-compensated relationship as a Board Member and Chair with My Epilepsy Story that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Speaker with Epilepsy Foundation that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with Epilepsy Ireland that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Member of Scientific Advisory Committee with North American AED Pregnancy Registry that is relevant to AAN interests or activities.
Bryce Allen Bagley Mr. Bagley has received personal compensation for serving as an employee of Stanford University.
Greer Waldrop, MD Dr. Waldrop has nothing to disclose.
Neil A. Busis, MD, FAAN Dr. Busis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Academy of Neurology. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today.
Amanda L. Jagolino-Cole, MD, FAAN Dr. Jagolino-Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology - Neurology Clinical Practice Journal. . The institution of Dr. Jagolino-Cole has received research support from McGovern Medical School at the University of Texas Health Science Center at Houston.
Elena Penhos, MD Ms. Penhos has nothing to disclose.
Kimberly Alexander, PhD Dr. Alexander has received personal compensation for serving as an employee of Verantos. Dr. Alexander has received personal compensation for serving as an employee of BioMarin. Dr. Alexander has stock in BioMarin.
Huzaifa Ahmad Cheema, MBBS Dr. Cheema has nothing to disclose.
Jennifer S. Hui, MD Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Hui has received research support from Roche. The institution of Dr. Hui has received research support from Abbvie. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Roundtable speaker with Medscape .
Eric Zimmerman Mr. Zimmerman has nothing to disclose.
Luisa Hildegard Klotz, MD Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Cristian Andres Correa, MD Dr. Correa has nothing to disclose.
Daniela Angst, PhD Dr. Angst has received personal compensation for serving as an employee of Novartis. Dr. Angst has stock in Novartis.
Eslam Mohammed Rabea Mr. Rabea has nothing to disclose.
Derrick Robertson, MD Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Jae-kwan Cha, MD,PhD Prof. Cha has nothing to disclose.
Rakhee Lalla, DO Dr. Lalla has received personal compensation in the range of $0-$499 for serving as a Consultant for Women's health initiative .
Triza Brion Triza Brion has received personal compensation for serving as an employee of ICON plc.
Bryce Grohol, Other Mr. Grohol has nothing to disclose.
Christopher D. Stephen, MB ChB FRCP SM Dr. Stephen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Jonathan Haroon Mr. Haroon has nothing to disclose.
Mohammad Taimur Shujaat Mohammad Taimur Shujaat has nothing to disclose.
Elizabeth Faust Murdoch, Other Mrs. Murdoch has received personal compensation for serving as an employee of Thirty Madison. Mrs. Murdoch has received personal compensation for serving as an employee of Analysis Group. Mrs. Murdoch has received stock or an ownership interest from Thirty Madison.
Carolina García Alfonso, MD Dr. García Alfonso has nothing to disclose.
Emily Feeney Ms. Feeney has nothing to disclose.
Marjie Hard No disclosure on file
Michelle Detry, PhD Dr. Detry has nothing to disclose.
James B. Lewin, PharmD Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Christopher Paul Robinson, DO Dr. Robinson has nothing to disclose.
Beatriz Cassarotti, MD Miss Cassarotti has nothing to disclose.
Federico J. Rodriguez-Porcel, MD An immediate family member of Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anmeal. Dr. Rodriguez-Porcel has received publishing royalties from a publication relating to health care.
Om Sakhalkar Mr. Sakhalkar has nothing to disclose.
Jonathan Stokes, Other Mr. Stokes has nothing to disclose.
Adam T. Mierzwa, MD Dr. Mierzwa has nothing to disclose.
Syed F. Zaidi, MD Dr. Zaidi has nothing to disclose.
Suzan Moser, RN Mrs. MOSER has stock in Medtronic. Mrs. MOSER has stock in Johnson and Johnson.
Simerun Singh, MD Dr. Singh has nothing to disclose.
Elina Zakin, MD The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Dhivyaa Rajasundaram, PhD Dr. Rajasundaram has nothing to disclose.
Sandra Kurcova, MD,PhD Miss Kurcova has nothing to disclose.
A. G. Christina Bergqvist, MD Dr. Bergqvist has nothing to disclose.
Emily Freitag, Other Ms. Freitag has nothing to disclose.
Mark Conaway Mark Conaway has nothing to disclose.
Shahid Nimjee No disclosure on file
Shanna Swartwood, MD Dr. Swartwood has nothing to disclose.
Eric Engebretson Mr. Engebretson has nothing to disclose.
Marion Oliver, MD Dr. Oliver has nothing to disclose.
Anas Mohammed Alrohimi, MD Dr. Alrohimi has nothing to disclose.
Lori B. Chibnik Lori B. Chibnik has nothing to disclose.
Steven Petrou Steven Petrou has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Praxis Precision Medicines. Steven Petrou has stock in Praxis Precision Medicines. The institution of Steven Petrou has received research support from Praxis Precision Medicines. The institution of Steven Petrou has received research support from Medical Research Future Fund. Steven Petrou has received intellectual property interests from a discovery or technology relating to health care. Steven Petrou has received intellectual property interests from a discovery or technology relating to health care.
Margherita Anna Rosa Daviddi, MD Mrs. Daviddi has nothing to disclose.
Jonathan Amiel, MD Dr. Amiel has nothing to disclose.
Sergei Petrov Mr. Petrov has nothing to disclose.
Salman Bhai, MD Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KabaFusion. Dr. Bhai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. Bhai has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Bhai has received publishing royalties from a publication relating to health care.
Devorah Segal, MD Dr. Segal has nothing to disclose.
Daniel O. Claassen, MD, FAAN Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark . The institution of Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Neuroscience. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HD Insights. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from Griffin Family Foundation. The institution of Dr. Claassen has received research support from Neurocrine. The institution of Dr. Claassen has received research support from Vaccinex. The institution of Dr. Claassen has received research support from AbbVie. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from Genentech/ Roche. The institution of Dr. Claassen has received research support from Prilenia. The institution of Dr. Claassen has received research support from Neurocrine/ HSG.
Dongliang Wang, PhD Dr. Wang has nothing to disclose.
Wolfgang Singer, MD Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Michael Zeineh Michael Zeineh has nothing to disclose.
Alan M. Rapoport, MD, FAAN Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie, Amgen, Biohaven, Cala Health, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews.
Mrabet Saloua Mrabet Saloua has nothing to disclose.
Ricardo Alonso Ricardo Alonso has nothing to disclose.
Steven K. Feske, MD Dr. Feske has received publishing royalties from a publication relating to health care.
Viktoriya Katsnelson, MD Dr. Katsnelson has nothing to disclose.
Mouna Bendjebara No disclosure on file
Patricia Bonilha Patricia Bonilha has nothing to disclose.
Jeremy D. Schmahmann, MD, FAAN Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Huanwen Chen, MD Dr. Chen has nothing to disclose.
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
James D. Bowen, MD Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyers Squibb. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bowen has received research support from Biogen IDEC. The institution of Dr. Bowen has received research support from Genentech. The institution of Dr. Bowen has received research support from Genzyme. The institution of Dr. Bowen has received research support from Novartis. The institution of Dr. Bowen has received research support from Roche.
Michael Spinner, Other Mr. Spinner has nothing to disclose.
Shannon Catherine Shipley, MD Dr. Shipley has nothing to disclose.
Oliver Elise Sterling-Angus, Other Mr. Sterling-Angus has nothing to disclose.
Holly Sim, MD Dr. Sim has nothing to disclose.
Artur Menegaz de Almeida Mr. Menegaz de Almeida has nothing to disclose.
Anita Rau, MD Dr. Rau has nothing to disclose.
Kevin Winthrop Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline (GSK). Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Union Chimique Belge (UCB). Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly & Co.. Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Galapagos. Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gilead. Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regeneron. Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Kevin Winthrop has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/ Genentech. Kevin Winthrop has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Kevin Winthrop has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly & Co. Kevin Winthrop has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Abigail S Betner, MLS Mrs. Betner has nothing to disclose.
Anupama Rani, PhD Dr. Rani has nothing to disclose.
Alexander Kaufman, Other Mr. Kaufman has nothing to disclose.
Bin Jiang, MD,PhD Dr. Jiang has nothing to disclose.
Soudeh Ansari Soudeh Ansari has received personal compensation for serving as an employee of Novartis.
Katrina Paumier, PhD Dr. Paumier has nothing to disclose.
Adam Raikes, PhD Dr. Raikes has nothing to disclose.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Hafsa Shahid, MBBS Ms. Shahid has nothing to disclose.
Ram Pathak, MD Dr. Pathak has nothing to disclose.
Binu Joseph Binu Joseph has nothing to disclose.
Susanne Awad, PhD Dr. Awad has nothing to disclose.
Jeffrey Wald Jeffrey Wald has received personal compensation for serving as an employee of Sage Therapeutics. Jeffrey Wald has received stock or an ownership interest from Sage Thereapeutics.
Lingchao Mao Ms. Mao has nothing to disclose.
Kyra Rose Steiner Ms. Steiner has nothing to disclose.
Kush Sharma, MBBS Dr. Sharma has nothing to disclose.
Mark Vangel Mark Vangel has nothing to disclose.
Sherry Fung Ms. Fung has nothing to disclose.
Shravan Sivakumar, MBBS Dr. Sivakumar has nothing to disclose.
Sudhanshu P. Raikwar, PhD Dr. Raikwar has nothing to disclose.
Nada Ahmed, MD Dr. Ahmed has nothing to disclose.
Ryan O'Mara, Other Mr. O'Mara has received personal compensation for serving as an employee of VIgil Neuroscience, LLC.
Jeffery R. Tenney, MD, PhD Dr. Tenney has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wilson Smith Cochran Dickerson. The institution of Dr. Tenney has received research support from NIH.
Alexa Walter Alexa Walter has nothing to disclose.
Filipe Branco Filipe Branco has received personal compensation for serving as an employee of Biogen. Filipe Branco has received stock or an ownership interest from Biogen.
Jose Pedro Falero Pomales, MD Dr. Falero Pomales has nothing to disclose.
Kory Johnson Kory Johnson, 2962 has nothing to disclose.
Samar Farouk Ahmed, MD Dr. Ahmed has nothing to disclose.
Latha Ganti, MD, MS, MBA, FACEP Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
Anthony A. Estrada, PhD Dr. Estrada has stock in Denali Therapeutics .
Constance *use 387035 McGraw Constance McGraw has nothing to disclose.
Madison McGann Ms. McGann has nothing to disclose.
Johannes Pulst-Korenberg, MD Dr. Pulst-Korenberg has nothing to disclose.
Saisree Ravi Ms. Ravi has nothing to disclose.
Kaneez Zahra, MD, MBBS Dr. Zahra has nothing to disclose.
Brandon Giglio, MD Dr. Giglio has nothing to disclose.
Jessica Stulc, MD Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono . Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD serono . Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi . The institution of Dr. Stulc has received research support from EMD serono . The institution of Dr. Stulc has received research support from Novartis . The institution of Dr. Stulc has received research support from Sanofi . The institution of Dr. Stulc has received research support from Genentech. The institution of Dr. Stulc has received research support from Biogen.
Vicki Shanker, MD, FAAN Dr. Shanker has nothing to disclose.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Brenda Banwell, MD, FAAN Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Rashmi B. Halker Singh, MD, FAAN Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.
Russell E. Bartt, MD, FAAN Dr. Bartt has nothing to disclose.
Shivika Chandra, MD The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in Education Award.
Amina Nasri, MD Dr. Nasri has nothing to disclose.
Mark S. Freedman, MD, FAAN Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Philip W. Tipton, MD Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Mekka Rae Garcia, MD Dr. Garcia has nothing to disclose.
Julien Rousseau, MD,CM Dr. Rousseau has nothing to disclose.
Emma Limehouse Wetmore Emma *Use 368242 Wetmore has nothing to disclose.
Krithika Umesh Peshwe, MD Dr. Peshwe has nothing to disclose.
Romeo Maciuca, PhD Mr. Maciuca has received personal compensation for serving as an employee of Denali Therapeutics. Mr. Maciuca has received stock or an ownership interest from Denali Therapeutics.
Ieshia Deal, Other Miss Deal has nothing to disclose.
Katerina Klicova, Other Mrs. Klicova has nothing to disclose.
Ryan Kaya, PT Mr. Kaya has nothing to disclose.
Elizabeth Matthews, MD Dr. Matthews has nothing to disclose.
Ernie Yulyaningsih, PhD Dr. Yulyaningsih has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Yulyaningsih has stock in Denali Therapeutics. Dr. Yulyaningsih has stock in 23 & ME. Dr. Yulyaningsih has stock in Ardelyx. Dr. Yulyaningsih has stock in Amylyx.
Eufrosina I. Young, MD The institution of Dr. Young has received research support from Mitsubishi Tanabe Pharma America.
Chaim T. Sneiderman Mr. Sneiderman has nothing to disclose.
David Vaillancourt David Vaillancourt has received personal compensation for serving as an employee of Automated Imaging Diagnostics. David Vaillancourt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of David Vaillancourt has received research support from NIH. David Vaillancourt has received intellectual property interests from a discovery or technology relating to health care.
Paul Wright, MD, FAAN Dr. Wright has nothing to disclose.
Michael Phipps, MD, MHS, FAAN Dr. Phipps has nothing to disclose.
Teena Shetty, MD, FAAN Dr. Shetty has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaeucticals. Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from Teva Pharmaceuticals Industry. The institution of Dr. Shetty has received research support from GE-NFL.
Asha Philip Jacob, MD,Other Dr. Jacob has nothing to disclose.
Joseph T Nguyen Joseph T Nguyen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The American Journal of Sports Medicine. Joseph T Nguyen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Women's Journal of Sports Medicine.
Nicholas Kento Sammond, DO Dr. Sammond has nothing to disclose.
Spyros Papapetropoulos No disclosure on file
Carol Aubrey Vitellas, MD Dr. Vitellas has nothing to disclose.
Jasem Yousef Al-Hashel, MD Dr. Al-Hashel has nothing to disclose.
Joshua Catapano, MD Dr. Catapano has nothing to disclose.
Michael Stefan Oldham, MD, MPH Dr. Oldham has received personal compensation for serving as an employee of Praxis Precision Medicines.
Zhu Hongtu Zhu Hongtu, 5036 has nothing to disclose.
Daniel Hudson Mr. Hudson has nothing to disclose.
Alexander Kashou Mr. Kashou has nothing to disclose.
Andy Cheadle, PhD Dr. Cheadle has received personal compensation for serving as an employee of Novartis. Dr. Cheadle has stock in Novartis. Dr. Cheadle has stock in Teva.
John William Lindsey, MD Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Muhammad Saim Mr. Saim has nothing to disclose.
Matthew Colm Kiernan, PhD, FRACP, MBBS The institution of Prof. Kiernan has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for British Medical Journal Publishers (UK).
Kholoud Yaser Altarazi, MD Dr. Altarazi has nothing to disclose.
Andree-Anne Berthiaume, PhD Dr. Berthiaume has received personal compensation for serving as an employee of Athira Pharma. Dr. Berthiaume has stock in Athira Pharma. An immediate family member of Dr. Berthiaume has stock in Athira Pharma.
Muhammad Ayyan, MBBS Mr. Ayyan has nothing to disclose.
Kriti Bhayana, MD Dr. Bhayana has nothing to disclose.
Roni Chau Miss Chau has received personal compensation for serving as an employee of Denali Therapeutics. Miss Chau has stock in Denali Therapeutics.
Amy Goldstein, MD Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reneo Pharmaceuticals .
Benjamin Stuart, MD Dr. Stuart has nothing to disclose.
Marina *Use 361162 Ziehn, PhD Dr. Ziehn has received personal compensation for serving as an employee of Novartis AG.
Prachi Mehndiratta, MD Dr. Mehndiratta has nothing to disclose.
Claire Riley, MD, FAAN Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viracta. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Rosemary Prianka Gomes, MD Dr. Gomes has nothing to disclose.
Samiksha Srivastava, MD Dr. Srivastava has nothing to disclose.
Carole Ho, MD No disclosure on file
Kanika Sharma Ms. Sharma has nothing to disclose.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Xin Ying Lee, Other Ms. Lee has received personal compensation for serving as an employee of Lundbeck A/S.
Pierce Brody Mr. Brody has nothing to disclose.
Federico Tiersen, Other Mr. Tiersen has received personal compensation for serving as an employee of Mindstep. Mr. Tiersen has stock in Mindstep. Mr. Tiersen has received research support from Imperial College London.
Angie Goldsberry Angie Goldsberry has received personal compensation for serving as an employee of Reata Pharmaceuticals.
Ivan Bozin Dr. Bozin has received personal compensation for serving as an employee of Biogen. Dr. Bozin has received personal compensation for serving as an employee of Arvelle Therapeutics. Dr. Bozin has stock in Biogen.
Roberta Diaz Brinton, PhD Roberta Diaz Brinton, PhD has nothing to disclose.
Dorota Konickova, Other Ms. Konickova has nothing to disclose.
Ece Bayram, MD, PhD The institution of Dr. Bayram has received research support from National Institute on Aging (K99AG073453). The institution of Dr. Bayram has received research support from Lewy Body Dementia Association. The institution of Dr. Bayram has received research support from National Institute of Neurological Disorders and Stroke.
Christopher Thomas Whitlow, MD Dr. Whitlow has nothing to disclose.
Jacob Ben Perlman, MD Dr. Perlman has nothing to disclose.
Melissa Armstrong, MD, MSc, FAAN The institution of Dr. Armstrong has received research support from National Institute of Aging. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. Dr. Armstrong has received research support from Parkinson Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Elizabeth Finger, MD, FAAN Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali Therapeutics. The institution of Dr. Finger has received research support from CIHR. The institution of Dr. Finger has received research support from Physician Servcices Incorporated. The institution of Dr. Finger has received research support from Weston Foundation. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Annual Meeting Course Director with American Academy of Neurology.
Elizabeth A. Coon, MD, FAAN Dr. Coon has nothing to disclose.
Carrie Michelle Hersh, DO, MSc, FAAN Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI.
Sahar Fatima Zafar, MD Dr. Zafar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corticare. Dr. Zafar has received research support from NIH.
Sabrina Paganoni, MD, PhD Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Sola. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Frequency Therapeutics. The institution of Dr. Paganoni has received research support from Amylyx. The institution of Dr. Paganoni has received research support from Revalesio. The institution of Dr. Paganoni has received research support from Alector. The institution of Dr. Paganoni has received research support from UCB. The institution of Dr. Paganoni has received research support from Biohaven. The institution of Dr. Paganoni has received research support from Clene. The institution of Dr. Paganoni has received research support from Prilenia. The institution of Dr. Paganoni has received research support from Seelos. The institution of Dr. Paganoni has received research support from Calico. The institution of Dr. Paganoni has received research support from Denali. The institution of Dr. Paganoni has received research support from Anelixis. The institution of Dr. Paganoni has received research support from Cytokinetics.
Umer Akbar, MD Dr. Akbar has nothing to disclose.
Gabor Toth, MD Dr. Toth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Toth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic.
Sydney Chatfield Ms. Chatfield has nothing to disclose.
Valerie Braddick, MD Ms. Braddick has nothing to disclose.
Charles Shaw Davis, PhD No disclosure on file
James Christian Hiana, MD Dr. Hiana has nothing to disclose.
Murat Sari, MD The institution of Dr. Sari has received research support from NIH/NINDS.
David J. Roh, MD Dr. Roh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Portola Pharmaceuticals.
Michelle Dompenciel, MD Dr. Dompenciel has nothing to disclose.
Marie-Abele Bind, PhD The institution of Dr. Bind has received research support from NIH.
Helio Afonso Ghizoni Teive, MD Dr. Teive has nothing to disclose.
Suzanne Hendrix, PhD Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has stock in Pentara.
Cheng Chin Wang, DO Dr. Wang has nothing to disclose.
Shivangi *use 121636 Vora No disclosure on file
Uttam K. Bodanapally, MBBS Dr. Bodanapally has nothing to disclose.
Todd Allen Maugans, MD Dr. Maugans has nothing to disclose.
Lance Lim, Other Mr. Lim has nothing to disclose.
Rescule-ALS Investigators No disclosure on file
Nameer Aladamat, MBBS Dr. Aladamat has nothing to disclose.
Sohum Desai Mr. Desai has nothing to disclose.
Diane Whalley Diane Whalley has received personal compensation for serving as an employee of RTI Health Solutions.
Andrea De Palma Mr. De Palma has received personal compensation for serving as an employee of ICON.
Shitiz K. Sriwastava, MBBS Dr. Sriwastava has nothing to disclose.
Annette Wundes, MD The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Fernanda Jacinto Pereira Teixeira, MD Dr. Jacinto Pereira Teixeira has nothing to disclose.
Jing Li, PhD Prof. Li has nothing to disclose.
Syed Mehdi Husaini Mr. Husaini has nothing to disclose.
Dariush Dowlatshahi, MD Dr. Dowlatshahi has nothing to disclose.
Shunsuke Koga, MD, PhD Dr. Koga has nothing to disclose.
Stuart Yarr Stuart Yarr has nothing to disclose.
Michaela Kaiserova Michaela Kaiserova has nothing to disclose.
Rajeshwari Mahalingam, MD Dr. Mahalingam has nothing to disclose.
Michael Quirk Michael Quirk has received personal compensation for serving as an employee of Sage Therapeutics. Michael Quirk has received stock or an ownership interest from Sage Therapeutics.
Chong Hyun Suh Prof. Suh has nothing to disclose.
Kristin R. Drake, Other Ms. Drake has nothing to disclose.
Maksim Osipov, PhD Dr. Osipov has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Osipov has stock in Denali Therapeutics. Dr. Osipov has received intellectual property interests from a discovery or technology relating to health care.
Tahereh Kamali Ms. Kamali has nothing to disclose.
Jenny Meyer, MD The institution of Dr. Meyer has received research support from Grifols. The institution of Dr. Meyer has received research support from Medicinova.
Conor Reid Mr. Reid has nothing to disclose.
Juan José Mendez Gallardo, MD Dr. Mendez Gallardo has nothing to disclose.
Steven Kymes Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Ethan *Use 376336 Rich, DO,Other An immediate family member of Mr. Rich has received personal compensation for serving as an employee of Centra .
Brian Edlow, MD Dr. Edlow has received research support from NIH.
Juan A. Vivanco-Suarez, MD Mr. Vivanco-Suarez has nothing to disclose.
Marianne Chase Marianne Chase has nothing to disclose.
Barry Stewart Willer, PhD Prof. Willer has nothing to disclose.
Phillip A. Low, MD, FAAN Dr. Low has nothing to disclose.
Jacqueline Marie Shannon Ms. Shannon has nothing to disclose.
Kevin Bickart, MD, PhD Dr. Bickart has nothing to disclose.
Patrick O'Connor, MD Dr. O'Connor has nothing to disclose.
Judith Ann Dunmore, Other Ms. Dunmore has nothing to disclose.
Brian M. Sauer, MD Dr. Sauer has nothing to disclose.
HEALEY ALS Platform Study Group No disclosure on file
Houman Khosravani, MD, PhD Dr. Khosravani has nothing to disclose.
Mahmoud Ahmed Khalifa Mr. Khalifa has nothing to disclose.
Timothy Earr Timothy Earr has received personal compensation for serving as an employee of Denali Therapeutics. Timothy Earr has stock in Denali Therapeutics.
Tom Petro Tom Petro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Tom Petro has received research support from Stuart Nichols ALS fund.
Lena Liu, MD Dr. Liu has nothing to disclose.
Daniel Campinho Schachter, MD Mr. Schachter has nothing to disclose.
Ehaab Naim Saleem, Other Mr. Saleem has nothing to disclose.
Jane Ekhtman Ms. Ekhtman has nothing to disclose.
Horacio C. Kaufmann, MD, FAAN Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly USA. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma UK Ltd. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Motric Bio.
Manon Auffret, PhD, PharmD Dr. Auffret has received personal compensation for serving as an employee of France Développement Electronique. The institution of Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Britannia. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Auffret has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Britannia. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Auffret has received research support from Association France Parkinson. The institution of Dr. Auffret has received research support from Homeperf. The institution of Dr. Auffret has received research support from LVL. The institution of Dr. Auffret has received research support from University of Rennes 1. The institution of Dr. Auffret has received research support from Aguettant. The institution of Dr. Auffret has received research support from Linde. The institution of Dr. Auffret has received research support from Plateforme Nationale pour la recherche sur la fin de vie. Dr. Auffret has received publishing royalties from a publication relating to health care.
Herbert Schreiber Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Monika Johal, MD Dr. Johal has nothing to disclose.
Lauren Moore Nelson, PhD Prof. Nelson has received personal compensation for serving as an employee of RTI Health Solutions.
Sally Norton, PhD,RN The institution of Prof. Norton has received research support from National Institutes of Health.
Joshua Lencke, Other Mr. Lencke has nothing to disclose.
Christopher Reading Dr. Reading has received personal compensation for serving as an employee of Biovie, Inc.. Dr. Reading has received intellectual property interests from a discovery or technology relating to health care.
Shan Ali, MD Mr. Ali has nothing to disclose.
Francesco Sacca, MD Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Raphael Rifkin-Zybutz, MD Dr. Rifkin-Zybutz has received personal compensation for serving as an employee of Mindset Technologies Ltd. Dr. Rifkin-Zybutz has received research support from National Institute for Health and Care Research.
Anna Newman Ms. Newman has nothing to disclose.
Andrea L.C. Schneider, MD, PhD Dr. Schneider has nothing to disclose.
Xixi Hu Ms. Hu has received personal compensation for serving as an employee of Novartis.
Jamir Pitton Rissardo, MD Dr. Pitton Rissardo has nothing to disclose.
Marija Zivcevska Ms. Zivcevska has nothing to disclose.
Stephan Kim Mr. Kim has nothing to disclose.
Melinda Christine Arthur, DO Dr. Arthur has nothing to disclose.
Muhammad Bilal Tariq, MBBS Dr. Tariq has nothing to disclose.
Jaroslaw Dulski Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VM Media Ltd.. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Radoslaw Lipinski 90 Consulting. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Dulski has received research support from Polish Neurological Society. Dr. Dulski has received research support from Polish National Agency for Academic Exchange.
Micah Etter, MD Dr. Etter has nothing to disclose.
Ludwig Kappos, MD, FAAN The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Yaacov Anziska, MD Dr. Anziska has nothing to disclose.
Gary L. Pattee, MD The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals.
Mohamad Abdalkader Mohamad Abdalkader has nothing to disclose.
Laura Danielian Laura Danielian has nothing to disclose.
Jessica Elizabeth Decker, DO Dr. Decker has nothing to disclose.
Colin Meyer Colin Meyer has received personal compensation for serving as an employee of Reata Pharmaceuticals. Colin Meyer has stock in Reata Pharmaceuticals.
Dawn Matthews Dawn Matthews has received personal compensation for serving as an employee of ADM Diagnostics, Inc. Dawn Matthews has received stock or an ownership interest from ADM Diagnostics Inc. The institution of Dawn Matthews has received research support from National Institutes of Health.
Dan Riskin, MD Dr. Riskin has received personal compensation for serving as an employee of Verantos.
Amira Souissi Amira Souissi has nothing to disclose.
Michael Paul Skolka, MD Dr. Skolka has nothing to disclose.
Clio A. Rubinos, MD Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qualtrics Inc. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity Pharmaceuticals. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Epilepsy Society . Dr. Rubinos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Marinus Pharmaceutical. Dr. Rubinos has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for American Epilepsy Society . The institution of Dr. Rubinos has received research support from University of North Carolina .
Amanda Penko Amanda Penko has nothing to disclose.
James Doherty, PhD Dr. Doherty has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Doherty has received stock or an ownership interest from Sage Therapeutics.
Ruchira M. Jha, MD Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.
Jean Rama Surya, Other Mr. Surya has nothing to disclose.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NexGen. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Toleranzia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Warren D. Lo, MD, FAAN The institution of Dr. Lo has received research support from NIH. Dr. Lo has received publishing royalties from a publication relating to health care.
Robin Chen Mr. Chen has nothing to disclose.
Paul Horn The institution of Paul Horn has received research support from NIH.
Matthew Baker Matthew Baker has nothing to disclose.
Han-Xiang Deng, MD Dr. Deng has nothing to disclose.
Samuel Lee, DO Dr. Lee has nothing to disclose.
Christopher Andrew Sheridan, CSCS Mr. Sheridan has nothing to disclose.
Kennedy Mahdavi, Other Ms. Mahdavi has nothing to disclose.
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Santiago Ortega Gutierrez, MD Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for microvention. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from IschemiaView. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH.
Jooyoung Lee, PhD The institution of Dr. Lee has received research support from National Research Foundation of Korea.
Joel Stein, MD The institution of Dr. Stein has received research support from BrainQ.
Jaime Donnelly, Other Miss Donnelly has nothing to disclose.
Patrick Youssef Patrick Youssef has nothing to disclose.
Yeoung Deok Seo Dr. Seo has nothing to disclose.
Ankita Tripathi, MD Dr. Tripathi has nothing to disclose.
Jason K. Johannesen, PhD,MD Dr. Johannesen has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Johannesen has stock in Sage Therapeutics . Dr. Johannesen has received research support from National Institute of Health. Dr. Johannesen has received research support from Brain & Behavior Research Foundation . Dr. Johannesen has received research support from VA office of Rehabilitation Research & Development.
Thabata Emanuelle Mart Nunes, Other Miss Nunes has nothing to disclose.
Timothy Ryan Miller, MD The institution of Dr. Miller has received research support from Medtronic. The institution of Dr. Miller has received research support from Cerenovus, DePuy Synthes Products, Inc.. The institution of Dr. Miller has received research support from InSightec. The institution of Dr. Miller has received research support from Microvention. The institution of Dr. Miller has received research support from Microvention. The institution of Dr. Miller has received research support from InSightec. The institution of Dr. Miller has received research support from MicroVention. The institution of Dr. Miller has received research support from InSightec. The institution of Dr. Miller has received research support from Vesalio.
Nicholas Mallett, MD Dr. Mallett has nothing to disclose.
Jian Xu, MD, PhD Dr. Xu has nothing to disclose.
Adesh Tandon, MD Dr. Tandon has nothing to disclose.
Samuel F. Hunter, MD, PhD The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
Michele Potashman, PhD Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Jorge Alexander Matta, MD Dr. Matta has nothing to disclose.
Briana Wasserstrom, DO Dr. Wasserstrom has nothing to disclose.
Tamela Stuchiner Ms. Stuchiner has nothing to disclose.
Biniyam Simeneh Mulatu, MD Dr. Mulatu has nothing to disclose.
Michael Hotchkin Mr. Hotchkin has received personal compensation for serving as an employee of Clene Nanomedicine, Inc. Mr. Hotchkin has stock in Clene Nanomedicine, Inc.
Gene Y. Sung, MD, MPH The institution of Dr. Sung has received research support from NIH.
Ian Shepherd Dorman Mr. Dorman has nothing to disclose.
Lauren Jackson, MD Dr. Jackson has nothing to disclose.
Aaron M. Carlson, MD Dr. Carlson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Carlson has received research support from Horizon Therapeutics. Dr. Carlson has a non-compensated relationship as a Health Service Subcommittee Member with American Academy of Neurology that is relevant to AAN interests or activities.
Martin Oselkin Mr. Oselkin has nothing to disclose.
Bruno Cenni Mr. Cenni has received personal compensation for serving as an employee of Novartis.
Piers Klein Mr. Klein has nothing to disclose.
Lucia Moiola, MD, PhD Dr. Moiola has nothing to disclose.
Teodoro Del Ser, MD,PhD Dr. Quijano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Sara Palacios, MD Dr. Palacios has nothing to disclose.
Prathyankara Premkumar No disclosure on file
Audrey Wadood, MD Dr. Wadood has nothing to disclose.
Scott Grossman, MD Dr. Grossman has nothing to disclose.
Jarrod Rulney Mr. Rulney has nothing to disclose.
Shavonne Massey, MD Dr. Massey has a non-compensated relationship as a consultant with Sun Pharmaceutical Ltd that is relevant to AAN interests or activities.
Ben Saville, PhD Dr. Saville has nothing to disclose.
Elizabeth Jansen Mrs. Jansen has nothing to disclose.
Margaux Miller Ms. Miller has nothing to disclose.
Ronald Zielman Dr. Zielman has received personal compensation for serving as an employee of Novartis.
Helena Digney, Other Miss Digney has nothing to disclose.
Jason Katz Mr. Katz has nothing to disclose.
Robert Pulz, PhD Dr. Pulz has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Pulz has stock in Novartis Pharma AG.
Werner Poewe, MD Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Robert Cowan, MD, FAAN Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care.
Diana Lehner-Gulotta Diana Lehner-Gulotta has nothing to disclose.
Fen Huang No disclosure on file
Jonathan R. Brent, MD, PhD Dr. Brent has received research support from The American Academy of Neurology.
Maurish Fatima Miss Fatima has nothing to disclose.
James J. Gugger, Jr., MD, PharmD Dr. Gugger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. The institution of Dr. Gugger has received research support from American Epilepsy Society.
Sheldon E. Jordan, MD Dr. Jordan has stock in Synaptec Network.
Sarah Lapointe, MD Dr. Lapointe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Mariah Connolly Mrs. Connolly has nothing to disclose.
Sarah Dobbins Ms. Dobbins has received personal compensation for serving as an employee of Denali Therapeutics. Ms. Dobbins has stock in Denali Therapeutics.
Imen Kacem, MD Dr. Kacem has nothing to disclose.
Ria Trivedi Miss Trivedi has nothing to disclose.
Sachin Agarwal, MD,MPH Dr. Agarwal has nothing to disclose.
Matteo Vestrucci, PhD Dr. Vestrucci has received personal compensation for serving as an employee of Berry Consultants. Dr. Vestrucci has received research support from the University of Texas at Austin.
Ramisha Aymon, Other Ms. Aymon has nothing to disclose.
Jena Malchiodi No disclosure on file
Sven G. Meuth Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Khushalee Oza Miss Oza has nothing to disclose.
Michael Kutch, Other Mr. Kutch has nothing to disclose.
Todd D. Levine, MD Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has stock in CND Life Sciences. Dr. Levine has stock in Corinthian reference lab.
Gabriel Rodriguez Gabriel Rodriguez has nothing to disclose.
Susan Durham Susan Durham has received personal compensation for serving as an employee of Biohaven. Susan Durham has stock in Biohaven.
Sara J. Hooshmand, MD Dr. Hooshmand has nothing to disclose.
Dafne Luana Bayer, MD Dr. Bayer has nothing to disclose.
Jinse Park, Sr., MD,PhD The institution of Dr. Park has received research support from Korean ministry of SMEs and Startups.
Julieta Casen Julieta Casen has nothing to disclose.
Florencia Capdeville, Other Dr. Capdeville has nothing to disclose.
Bernard M. Ravina, MD, MSCE Dr. Ravina has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Ravina has stock in Praxis.
Jenna Seckar, Other Ms. Seckar has nothing to disclose.
Muhammad Aemaz Ur Rehman, MD Mr. Aemaz Ur Rehman has nothing to disclose.
Shruthi Harish, MBBS Dr. Harish has nothing to disclose.
David Bar-Or David Bar-Or has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Ampio Pharmaceuticals. David Bar-Or has stock in Ampio Pharmaceuticals.
Carolyn Cronin, MD, PhD, FAAN Dr. Cronin has nothing to disclose.
Parvathi Menon The institution of Parvathi Menon, 5121 has received research support from MNDRA.
Victoria Leavitt, PhD, FAAN Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Isabella Huang Ms. Huang has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Paul Steven Giacomini, MD Dr. Giacomini has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Innodem Neurosciences. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for F. Hoffmann- La Roche. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffmann-La Roche. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffman-La Roche. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi.
Olaf Hoffmann, MD Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hoffmann has received research support from Biogen. The institution of Dr. Hoffmann has received research support from Novartis. The institution of Dr. Hoffmann has received research support from Sanofi.
Deborah Taylor, Other Ms. Taylor has nothing to disclose.
Todd J. Schwedt, MD, FAAN Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Science. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Linpharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Schwedt has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. The institution of Dr. Schwedt has received research support from Amgen. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Ibolya Boer Ibolya Boer has received personal compensation for serving as an employee of Novartis AG.
Matei A. Armanasu Mr. Armanasu has nothing to disclose.
Trevor Nelson Mr. Nelson has nothing to disclose.
Victoria Venkatraman Ms. Venkatraman has nothing to disclose.
Kaylee Kang Ms. Kang has nothing to disclose.
Rachel Kenney Rachel Kenney has nothing to disclose.
Eric A. Macklin, PhD The institution of Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AI Therapeutics. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chase Therapeutics. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson Healthcare LLC. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Macklin has received research support from Biohaven. The institution of Dr. Macklin has received research support from Clene Nanomedicine. The institution of Dr. Macklin has received research support from Mitsubishi Tanabe Pharmaceuticals America. The institution of Dr. Macklin has received research support from Prilenia. The institution of Dr. Macklin has received research support from UCB Ra Pharma. The institution of Dr. Macklin has received research support from Revalesio. The institution of Dr. Macklin has received research support from Seelos. The institution of Dr. Macklin has received research support from Calico. The institution of Dr. Macklin has received research support from Denali. The institution of Dr. Macklin has received research support from NeuroDex. The institution of Dr. Macklin has received research support from Alector. The institution of Dr. Macklin has received research support from ITB-Med.
Mia T. Minen, MD, FAAN Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine Journal. The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Takakuni Maki Takakuni Maki has nothing to disclose.
Maariyah Kharal Miss Kharal has nothing to disclose.
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN Dr. Sankaraneni has nothing to disclose.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Sami Alkasab, MD No disclosure on file
John J. Leddy, MD, FACSM, FACP Dr. Leddy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolign. Dr. Leddy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stage 2 Contract Engineering. Dr. Leddy has received stock or an ownership interest from Highmark Innovations. The institution of Dr. Leddy has received research support from NIH. The institution of Dr. Leddy has received research support from DoD. The institution of Dr. Leddy has received research support from AMSSM.
Sharon Hammond-Heaton, RN Ms. Hammond-Heaton has nothing to disclose.
Anna Moroz, MD Dr. Moroz has nothing to disclose.
Abbas Kharal, MD Dr. Kharal has nothing to disclose.
Juliana Rose, Other Miss Rose has nothing to disclose.
Cecilia *Use 353293 Quarraccino No disclosure on file
Reece Hass, DO Dr. Hass has nothing to disclose.
Narayan Kuleindiren Mr. Kuleindiren has nothing to disclose.
Alessandra Filpo, MD Dr. Filpo has nothing to disclose.
Daniel Broderick Daniel Broderick has nothing to disclose.
Nada A. Hindiyeh, MD Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck .
Kathleen Rodgers Kathleen Rodgers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Proneurogen. Kathleen Rodgers has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Regulonix. Kathleen Rodgers has received intellectual property interests from a discovery or technology relating to health care.
Oscar Danilo Ortega, MD Dr. Ortega has nothing to disclose.
Meghan Hall No disclosure on file
Gerson David Hernandez Rivera, MD, MPH Dr. Hernandez Rivera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuTherapeutics. The institution of Dr. Hernandez Rivera has received research support from National Institute on Aging. The institution of Dr. Hernandez Rivera has received research support from National Institute on Aging.
Bakhtawar Ahmad, MBBS No disclosure on file
Jose Miguel Valdes Valdes, MD Dr. Valdes has nothing to disclose.
Samuel Durojaye, MD Dr. Durojaye has nothing to disclose.
Malak AlMojel, MD Dr. AlMojel has nothing to disclose.
Maysen Mesaros Maysen Mesaros has nothing to disclose.
Patrick M. Kochanek, MD, MCCM Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Johns Hopkins Health System. The institution of Patrick M. Kochanek, MD, MCCM has received research support from Chuck Noll Foundation. The institution of Patrick M. Kochanek, MD, MCCM has received research support from NIH. Patrick M. Kochanek, MD, MCCM has received publishing royalties from a publication relating to health care.
Dheeraj Gandhi Dheeraj Gandhi has nothing to disclose.
Huw R. Morris, MD, PhD Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Morris has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Personal injury / Negligence cases. The institution of Dr. Morris has received research support from Parkinson's UK. The institution of Dr. Morris has received research support from Michael J Fox Foundartion. The institution of Dr. Morris has received research support from Cure Parkinson's Trust. The institution of Dr. Morris has received research support from PSP Association. The institution of Dr. Morris has received research support from CBD Solutions. The institution of Dr. Morris has received research support from Drake Foundation. The institution of Dr. Morris has received research support from Medical Research Council. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Cure PSP that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Parkinson's UK that is relevant to AAN interests or activities.
Daniel Minsuk Oh, MD Dr. Oh has nothing to disclose.
Jubin Kang Ms. Kang has nothing to disclose.
Peggy Auinger Ms. Auinger has nothing to disclose.
Gaurav Jindal Gaurav Jindal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Penumbra.
Glenn Thurston Stebbins, PhD Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Letizia Mazzini Letizia Mazzini has nothing to disclose.
Charles Kassardjian, MD Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Randheer Yadav Randheer Yadav has stock in Quest Recovery Center LLC.
Sungyang Jo, MD Dr. Jo has nothing to disclose.
Khaled Gharaibeh, MD Dr. Gharaibeh has nothing to disclose.
Tiffany Lago, MD Dr. Lago has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Lago has stock in Sage Therapeutics.
Gina Mavrikis Cox, PhD Dr. Mavrikis Cox has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Dr. Mavrikis Cox has stock in Novartis Pharmaceuticals.
Matthew Swan, MD Dr. Swan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NACME. The institution of Dr. Swan has received research support from Sanofi Genzyme. The institution of Dr. Swan has received research support from Biogen. The institution of Dr. Swan has received research support from Sage Therapeutics.
Marco Colasurdo, MD Dr. Colasurdo has nothing to disclose.
Alexander Sherman The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Marianella Hernandez No disclosure on file
Shashvat Desai, MD Dr. Desai has nothing to disclose.
Carolyn Tsai, MD Dr. Tsai has nothing to disclose.
Yahia M. Lodi, MD, FAAN Dr. Lodi has nothing to disclose.
Ariel Antezana, MD Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Joseph Michael Palumbo, MD Dr. Palumbo has received personal compensation for serving as an employee of BioVie. An immediate family member of Dr. Palumbo has received personal compensation for serving as an employee of Merck Research Laboratories. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BioVie. Dr. Palumbo has stock in BioVie. An immediate family member of Dr. Palumbo has stock in Merck Research Laboratories. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care.
Maha *Use 279902 Daimee No disclosure on file
Madeline Garza, MD Dr. Garza has nothing to disclose.
Shima Shahjouei, MD, MPH Dr. Shahjouei has nothing to disclose.
Alani Jack Ms. Jack has nothing to disclose.
Teresa Wu, PhD Dr. Wu has nothing to disclose.
Ge Cheng Miss Cheng has nothing to disclose.
Emanuel Cassou, MD Dr. Cassou has nothing to disclose.
Joanna Hong Miss Hong has nothing to disclose.
Kenny Phan, Other Mr. Phan has nothing to disclose.
Fatemah Alshawaf, MD Dr. Alshawaf has nothing to disclose.
Sola Park, PhD Dr. Park has nothing to disclose.
Otto Jesus Hernandez Fustes, MD, PhD, FAAN Dr. Hernandez Fustes has nothing to disclose.
Kathy Merlo, Other Mrs. Merlo has nothing to disclose.
Jay L Alberts, PhD The institution of Dr. Alberts has received research support from NIH. Dr. Alberts has received intellectual property interests from a discovery or technology relating to health care. Dr. Alberts has received personal compensation in the range of $500-$4,999 for serving as a Member, Health and Wellness Council with Peloton Interactive.
Florian Then Bergh, MD Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actelion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fresenius. The institution of Dr. Then Bergh has received research support from Actelion. The institution of Dr. Then Bergh has received research support from Novartis. The institution of Dr. Then Bergh has received research support from DFG (German Science Fund). Dr. Then Bergh has received personal compensation in the range of $10,000-$49,999 for serving as a Member of the Institutional Ethics Board with University of Leipzig, Medical Faculty.
Aditya S. Pandey, MD Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NIH and SVIN- Journal. Dr. Pandey has stock in FlexDex. Dr. Pandey has stock in NextGen. The institution of Dr. Pandey has received research support from NIH. The institution of Dr. Pandey has received research support from Focused ultrasound foundation. Dr. Pandey has received intellectual property interests from a discovery or technology relating to health care.
Mehul Mehra Mr. Mehra has received research support from Medical College of Georgia. Mr. Mehra has received personal compensation in the range of $500-$4,999 for serving as a Graduate SGA Humanitarian with Augusta University.
Stephane Regnier, PhD Mr. Regnier has received personal compensation for serving as an employee of Lundbeck. Mr. Regnier has received personal compensation for serving as an employee of Novartis. Mr. Regnier has stock in Novartis.
Sun Ju Chung, MD, PhD, FAAN Dr. Chung has nothing to disclose.
Bridget Ollesch, MD Dr. Ollesch has nothing to disclose.
Karissa Hastilow Karissa Hastilow has nothing to disclose.
Zujian Xiong, MD,PhD Dr. Xiong has nothing to disclose.
Margaret Zielinski Ms. Zielinski has nothing to disclose.
Julia Savva Dr. Savva has nothing to disclose.
Philip Mathew, MD Dr. MATHEW has nothing to disclose.
Bijan Pourat, MD Dr. POURAT has nothing to disclose.
Robert T. Naismith, MD, FAAN Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Sravanthi Koduri No disclosure on file
Ivy Charlotte Snyder Mrs. Snyder has received research support from American Headache Society - Frontiers in Headache Scholarship.
Parth Udayan Thakker, MD Dr. Thakker has nothing to disclose.
Muhammad Shazam Hussain, MD Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Guillaume Robert Guillaume Robert has nothing to disclose.
Mudassir Farooqui, MD Dr. Farooqui has nothing to disclose.
Alexandra L. Dobie, Other Ms. Dobie has nothing to disclose.
Shivani Ghoshal, MD Dr. Ghoshal has nothing to disclose.
Mouhammad A. Jumaa, MD Dr. Jumaa has nothing to disclose.
Victoria Wirtz Victoria Wirtz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Victoria Wirtz has stock in Biohaven Pharmaceuticals, Inc.
Mazhar Khalid, MD, MBBS Dr. Khalid has nothing to disclose.
Danielle Sandsmark, MD The institution of Dr. Sandsmark has received research support from NINDS.
Kaho Onomichi Kaho Onomichi has nothing to disclose.
Fabiola De Marchi Fabiola De Marchi has nothing to disclose.
Angela Wabulya, MB ChB Dr. Wabulya has nothing to disclose.
Olivier Gevaert Prof. Gevaert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Prof. Gevaert has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Communications Medicine. The institution of Prof. Gevaert has received research support from Onc.AI. The institution of Prof. Gevaert has received research support from Roche Molecular Systems. The institution of Prof. Gevaert has received research support from Owkin.
Hong Yu, MD No disclosure on file
Steven Vernino, MD, PhD, FAAN Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Grifols. The institution of Dr. Vernino has received research support from Dysautonomia International. The institution of Dr. Vernino has received research support from BioHaven. The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities.
Hemali Phatnani, PhD Dr. Phatnani has nothing to disclose.
Amina Gargouri Amina Gargouri has nothing to disclose.
Marcell Paul Szabo Mr. Szabo has nothing to disclose.
Rahul Chandra, MD Dr. Chandra has nothing to disclose.
Michelle HS Tosin, PhD, RN Dr. Tosin has nothing to disclose.
Page B. Pennell, MD, FAAN The institution of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Department of Defense. The institution of an immediate family member of Dr. Pennell has received research support from Environmental Protection Agency. The institution of an immediate family member of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Advanced Energy Consortium. Dr. Pennell has received publishing royalties from a publication relating to health care.
Clifton Lewis, DO Dr. Lewis has nothing to disclose.
Ghazala T. Saleem Dr. Saleem has nothing to disclose.
Rohini D. Samudralwar, MD Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Sara Berman Mitchell, MD Dr. Mitchell has nothing to disclose.
Brian Silver, MD, FAAN Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Dan H. Moore, PhD Dr. Moore has nothing to disclose.
Eva Franzova, MD Dr. Franzova has nothing to disclose.
Ryoichi Inoue, MD Dr. Inoue has nothing to disclose.
Jeremy Ader, MD Dr. Ader has nothing to disclose.
Patti Bratina, RN Ms. Bratina has nothing to disclose.
Rachael Coleman, Other Ms. Coleman has nothing to disclose.
Rosario Vasta, MD Dr. Vasta has nothing to disclose.
Charles R. Joseph, MD Dr. Joseph has nothing to disclose.
Jacob Cherian No disclosure on file
Melania H. Fanok, PhD Dr. Fanok has received personal compensation for serving as an employee of Denali Therapeutics . An immediate family member of Dr. Fanok has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cincor Pharma. Dr. Fanok has stock in Denali Therapeutics.
Andrew Schuster Andrew Schuster has nothing to disclose.
Matthew Sontag Davitz, MD Dr. Davitz has nothing to disclose.
Lorna Marisalva Galleguillos Goiry Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi.
Aaron Koenig Aaron Koenig has received personal compensation for serving as an employee of Sage Therapeutics.
Katerina Mensikova Katerina Mensikova has nothing to disclose.
Marcelo Rocha, MD, PhD The institution of Dr. Rocha has received research support from NIH.
Benzi Kluger, MD, FAAN The institution of Dr. Kluger has received research support from NIH. The institution of Dr. Kluger has received research support from PCORI.
Dennis William Simon, MD Dr. Simon has nothing to disclose.
James Van Etten James Van Etten has nothing to disclose.
Nils Henninger, MD, PhD, FANA Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals, Inc.. The institution of Dr. Henninger has received research support from DoD. The institution of Dr. Henninger has received research support from NIH.
Kathryn Margaret Grimes, MD Dr. Grimes has nothing to disclose.
Roger Cady, MD Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Cordula Weiss, PhD Dr. Weiss has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Gale R. Kittle, RN Mrs. Kittle has nothing to disclose.
Michelle Kaku, MD Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Ashraf Hassan El-banna Mr. El-banna has nothing to disclose.
Jeffrey Ware Jeffrey Ware has nothing to disclose.
Alexander Mauskop, MD, FAAN Dr. Mauskop has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lily. Dr. Mauskop has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Amit Kansara, MD Dr. Kansara has nothing to disclose.
Brian Dewar No disclosure on file
Muhammad Faiq Umar, MBBS Dr. Umar has nothing to disclose.
Ryosuke Takahashi, MD Dr. Takahashi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kan Institute. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharma. Dr. Takahashi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Ono Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenix. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnyrum. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sumitomo Pharma. The institution of Dr. Takahashi has received research support from MEXT. Japan. The institution of Dr. Takahashi has received research support from AMED, Japan. The institution of Dr. Takahashi has received research support from JST, Japan. The institution of Dr. Takahashi has received research support from MHLW, Japan. The institution of Dr. Takahashi has received research support from Sumitomo Pharma. The institution of Dr. Takahashi has received research support from Takeda Pharma. The institution of Dr. Takahashi has received research support from Otsuka Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a PO with AMED, Japan. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a PO with JST, Japan.
Nicholas J. Maragakis, MD, FAAN Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UptoDate. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharmaceuticals. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. An immediate family member of Dr. Maragakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Basketball Association. Dr. Maragakis has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Akava. An immediate family member of Dr. Maragakis has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Johns Hopkins Howard County Medical Center. Dr. Maragakis has stock in Akava. The institution of Dr. Maragakis has received research support from NIH/NINDS. The institution of Dr. Maragakis has received research support from Department of Defense. The institution of Dr. Maragakis has received research support from Maryland Stem Cell Research Fund. Dr. Maragakis has received intellectual property interests from a discovery or technology relating to health care.
Francois Bethoux, MD No disclosure on file
Vanessa Dwairi, MD Dr. Dwairi has nothing to disclose.
Jesse Fischer No disclosure on file
Jessica Kiarashi, MD Dr. Kiarashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for COVE.
Sonal Sharma, MD Dr. Sharma has nothing to disclose.
Afra Zahid, MBBS Miss Zahid has nothing to disclose.
Christina Szperka The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Szperka has received research support from Pfizer. Dr. Szperka has received research support from FDA.
Maria J. Bruzzone, MD Dr. Bruzzone has nothing to disclose.
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Waseem Khaliq, MD Dr. Khaliq has nothing to disclose.
Stephanie Allien, PA Mrs. Allien has nothing to disclose.
Sophie Arnould Sophie Arnould has nothing to disclose.
Klaas Wierenga Klaas Wierenga has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMC Medical Genomics .
Kaitlyn Lillemoe, MD Dr. Lillemoe has nothing to disclose.
Vittorio Martinelli Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Hope Ajom Okpokam, MD Dr. Okpokam has nothing to disclose.
Clarence Ahlem Mr. Ahlem has received personal compensation for serving as an employee of Biovie, Inc.. Mr. Ahlem has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Biovie, Inc.. Mr. Ahlem has received intellectual property interests from a discovery or technology relating to health care.
Stephanie Parker No disclosure on file
Myla D. Goldman, MD, MSC, FAAN Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Seronon. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen, IDEC. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ADAMAS. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., .
Audrey Strongosky Audrey Strongosky has nothing to disclose.
Kris Kahlig, PhD Dr. Kahlig has received personal compensation for serving as an employee of Praxis Precisoin Medicines. Dr. Kahlig has stock in Praxis Precision Medicines.
Brooke L. Valdez, Other Ms. Valdez has a non-compensated relationship as a Valdez with The Rocky Mountain MS Center non-profit partner that is relevant to AAN interests or activities.
Allison Snyder, MD Dr. Snyder has nothing to disclose.
Christian Parks Mr. Parks has nothing to disclose.
Zbigniew K. Wszolek, MD, FAAN Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica.
Martin *Use 130037 Weber, MD Martin Weber, MD has nothing to disclose.
Everton Bruno Castanha, MD Mr. CASTANHA has nothing to disclose.
Hans H. Shuhaiber, MD Dr. Shuhaiber has nothing to disclose.
Jules Heuberger, PhD Dr. Heuberger has received personal compensation for serving as an employee of Centre for Human Drug Research.
Ashley Nelson, DO Dr. Nelson has nothing to disclose.
Delini Sivakumar, MD Dr. Sivakumar has nothing to disclose.
Leo Coutinho, MD Dr. Coutinho has nothing to disclose.
Alejandro Murad, PhD Dr. Murad has received personal compensation for serving as an employee of UCB. Dr. Murad has received personal compensation for serving as an employee of Skyhawk Therapeutics. Dr. Murad has stock in Forma Therapeutics. Dr. Murad has stock in Skyhawk Therapeutics.
Irfan Qureshi, MD Dr. Qureshi has received personal compensation for serving as an employee of Biohaven.
Helen Brugger No disclosure on file
Elke Schipani Bailey, MD Dr. Schipani Bailey has nothing to disclose.
Melissa M. Cortez, DO The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Amgen Independent Investigator Award. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Ritvij Bowry, MD Dr. Bowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca.
MacKenzie Dunlap Mrs. Dunlap has nothing to disclose.
David Dunigan The institution of David Dunigan has received research support from University of Nebraska.
Andres Felipe Cardenas Cruz, Jr., MD Dr. Cardenas Cruz has nothing to disclose.
Antonio Canosa Antonio Canosa has nothing to disclose.
Cynthia Wong Cynthia Wong has received personal compensation for serving as an employee of Alterity Therapeutics.
Gilbert J. L'Italien Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Cugnasco Paolo Cugnasco Paolo has nothing to disclose.
Stephanie Qianhui Liang, MD Dr. Liang has nothing to disclose.
Kayla Nicole Kleist Mrs. Kleist has received personal compensation for serving as an employee of Athira Pharma. Mrs. Kleist has received personal compensation for serving as an employee of Alpine Immune Sciences. Mrs. Kleist has stock in Athira Pharma. Mrs. Kleist has stock in Alpine Immune Sciences.
Isaac V. Cohen, Other Dr. Cohen has received personal compensation for serving as an employee of Denali. Dr. Cohen has stock in Denali.
Irina Agarkova Irina Agarkova has nothing to disclose.
Elijah Stommel, MD, FAAN Dr. Stommel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Suslick Attorney. The institution of Dr. Stommel has received research support from CDC.
William Huynh, MD Dr. Huynh has nothing to disclose.
Leslie Corless The institution of Leslie Corless has received research support from Boehringer Ingelheim.
Morgan McGrath Mrs. McGrath has received research support from NIH. Mrs. McGrath has received intellectual property interests from a discovery or technology relating to health care.
Jessie Iregui Miss Iregui has nothing to disclose.
Colin Mahoney, FRACP,PhD,MBBS The institution of Dr. Mahoney has received research support from MNR Research Australia.
Carter Alden Bell Mr. Bell has nothing to disclose.
Katherine Emily Leaver, MD Dr. Leaver has nothing to disclose.
Cristina M. Ramo, MD Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANDOZ. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ramo has received research support from HORIZON-2020. The institution of Dr. Ramo has received research support from fis (SPANISH GOVERNMENT). The institution of Dr. Ramo has received research support from BIOGEN. The institution of Dr. Ramo has received research support from MERCK. The institution of Dr. Ramo has received research support from ALMIRALL. The institution of Dr. Ramo has received research support from NOVARTIS. The institution of Dr. Ramo has received research support from RICORS (Spanish Government). The institution of Dr. Ramo has received research support from ROCHE. Dr. Ramo has received publishing royalties from a publication relating to health care.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ziemssen has received research support from Biogen. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from Celgene.
James D. Berry, MD MPH Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene Nanomedicine. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma Holdings of America. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Berry has stock in ReactNeuro. The institution of Dr. Berry has received research support from Biogen. The institution of Dr. Berry has received research support from MT Pharma of America. The institution of Dr. Berry has received research support from Rapa Therapeutics. The institution of Dr. Berry has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Berry has received research support from Alexion. The institution of Dr. Berry has received research support from nQ Medical. The institution of Dr. Berry has received research support from ALSA. The institution of Dr. Berry has received research support from MDA. The institution of Dr. Berry has received research support from Amylyx. The institution of Dr. Berry has received research support from Transposon. Dr. Berry has a non-compensated relationship as a Scientific Advisor with Everything ALS that is relevant to AAN interests or activities.
Christopher Charles Anderson, MD Dr. Anderson has nothing to disclose.
Kristin Reilly Kristin Reilly has received personal compensation for serving as an employee of Janssen Scientific Affairs, LLC. Kristin Reilly has stock in Johnson & Johnson.
Kimiyoshi Kobayashi, MD Dr. Kobayashi has nothing to disclose.
Mehdi Ghasemi, MD Dr. Ghasemi has nothing to disclose.
Sander Connolly Sander Connolly has received intellectual property interests from a discovery or technology relating to health care.
James Simples, Jr., PhD Dr. Simples has stock in Janssen.
Mordechai Z. Smith, MD Dr. Smith has nothing to disclose.
Christopher Giza, MD, FAAN Dr. Giza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highmark Interactive. Dr. Giza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceutical. Dr. Giza has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Lewitt, Hackman, Shapiro, Marshall & Harlan. Dr. Giza has received stock or an ownership interest from Highmark Interactive. The institution of Dr. Giza has received research support from NCAA. The institution of Dr. Giza has received research support from US Department of Defense. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care.
Jordan Langford, Other Mr. Langford has nothing to disclose.
Patricio Millar Vernetti, MD The institution of Dr. Millar Vernetti has received research support from NIH. The institution of Dr. Millar Vernetti has received research support from Theravance. Dr. Millar Vernetti has received personal compensation in the range of $500-$4,999 for serving as a Speaker with WPC.
Adam B. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thirty Madison. Dr. Cohen has received stock or an ownership interest from Thirty Madison.
Enrico Matteoni Dr. Matteoni has nothing to disclose.
Marta Fernandes, PhD Dr. Fernandes has nothing to disclose.
Meghna Trivedi, MD Dr. Trivedi has nothing to disclose.
Sandhya Seshadri, PhD Dr. Seshadri has nothing to disclose.
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Bayer, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer, Biogen, Novartis, Merck, Roche, Sanofi.
Jeffrey Alan Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Robert L. Glanzman, MD, FAAN Dr. Glanzman has received personal compensation for serving as an employee of Clene Nanomedicine Inc. Dr. Glanzman has stock in Clene Nanomedicine Inc .
Gary Kohanbash, PhD The institution of Dr. Kohanbash has received research support from NIH.
Mark Chapman, PhD Dr. Chapman has received personal compensation for serving as an employee of Ligand. Dr. Chapman has stock in Ligand.
Brittany Flores, PhD Dr. Flores has nothing to disclose.
Arsen Askandaryan Dr. Askandaryan has nothing to disclose.
Shyeilla V. Dhuria, PhD Dr. Dhuria has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Dhuria has stock in Denali Thereapeutics.
Leonardino Digma, MD Mr. Digma has nothing to disclose.
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Lon Schneider, MD Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immue. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Athira. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha-cognition. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corium. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortexyme. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Ltd. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Eli Lilly. The institution of Dr. Schneider has received research support from Biogen. The institution of Dr. Schneider has received research support from Biohaven.
Elisabeth Rindner Ms. Rindner has nothing to disclose.
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Pharma. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Cytokinetics. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Brooks has received research support from Orion. Dr. Brooks has received research support from Alexion. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. The institution of Dr. Brooks has received research support from Biohaven. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities.
Daniela *use 109247 Piani Meier, PhD Dr. Piani Meier has received personal compensation for serving as an employee of Novartis. Dr. Piani Meier has received personal compensation for serving as an employee of Merck Group.
Nancy Fischbein, MD Dr. Fischbein has received publishing royalties from a publication relating to health care.
Angelo Volandes Dr. Volandes has nothing to disclose.
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Maria Virginia Diaz Rojas, MD Dr. Diaz Rojas has nothing to disclose.
Ajay Malhotra Ajay Malhotra, 9122 has nothing to disclose.
Mandip Singh Dhamoon, MD, MPH Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Justin Y. Kwan, MD, FAAN Dr. Kwan has received research support from National Institutes of Health. Dr. Kwan has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with National Institutes of Health.
Matthieu Bereau Matthieu Bereau has nothing to disclose.
Suzannah Ryan Dr. Ryan has received personal compensation for serving as an employee of Novartis.
Carrie Nicole Sawyers, RN Mrs. Sawyers has nothing to disclose.
Brent A. Willman-Yoswa Mr. Willman-Yoswa has received personal compensation for serving as an employee of Denali Therapeutics.
Alessandro Meani Alessandro Meani has nothing to disclose.
Megan Dini, MA Mrs. Dini has received personal compensation for serving as an employee of Parkinson's Foundation .
Vincent Vagni Vincent Vagni has nothing to disclose.
Andrew Heim Andrew Heim has nothing to disclose.
Margie Campbell, IV, RN Mrs. Campbell has nothing to disclose.
Daniel Torres, MD Dr. Torres has received publishing royalties from a publication relating to health care.
Robert P. Bowser, PhD Dr. Bowser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MT Pharma USA. Dr. Bowser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bowser has stock in nVector. Dr. Bowser has received intellectual property interests from a discovery or technology relating to health care.
Asher Tulsky, MD Dr. Tulsky has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Internal Medicine.
Gabriel Marinheiro Marinheiro Dos Santos-Bezerra, Sr., Other Mr. Dos Santos-Bezerra has nothing to disclose.
Linus D Sun, MD, PhD Dr. Sun has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Sun has stock in Denali Therapeutics.
Danyaal Buttar Mr. Buttar has nothing to disclose.
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Mohamed *use 351751 Zaazouee Dr. Zaazouee has nothing to disclose.
David R. Lynch, MD, PhD The institution of Dr. Lynch has received research support from reata. The institution of Dr. Lynch has received research support from PTC. Dr. Lynch has received intellectual property interests from a discovery or technology relating to health care.
Noopur Singh Noopur Singh has nothing to disclose.
Enrique Urrea-Mendoza, MD Dr. Urrea-Mendoza has nothing to disclose.
Umberto Manera, MD Dr. Manera has nothing to disclose.
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Visar Berisha Visar Berisha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Visar Berisha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer Ingelheim. Visar Berisha has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Aural Analytics. Visar Berisha has received stock or an ownership interest from Aural Analytics. The institution of Visar Berisha has received research support from Boheringer Ingelheim. Visar Berisha has received intellectual property interests from a discovery or technology relating to health care.
Sondra Zabar Sondra Zabar has nothing to disclose.
Matthew Scaramozza Mr. Scaramozza has received personal compensation for serving as an employee of Biogen. Mr. Scaramozza has stock in Biogen. Mr. Scaramozza has received intellectual property interests from a discovery or technology relating to health care.
Shuai Huang Mr. Huang has nothing to disclose.
Hiroaki Sekiya, MD, PhD Dr. Sekiya has nothing to disclose.
Katelyn A. Nelson No disclosure on file
Angela M. Velazquez, MD Dr. Velazquez has nothing to disclose.
Yohannes Simeneh Mulatu, MD Dr. Mulatu has nothing to disclose.
Derek Jason Roberts, MD,PhD Dr. Roberts has nothing to disclose.
Ibrahim Turkoz, PhD Dr. Turkoz has received personal compensation for serving as an employee of Janssen R&D. Dr. Turkoz has received stock or an ownership interest from J&J.
Theodore B Stem Theodore B Stem has nothing to disclose.
Günter *use 140694 Höglinger No disclosure on file
Ashley Santilli, MD Dr. Santilli has nothing to disclose.
David A. Stamler, MD Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics.
Ayan Das Gupta Ayan Das Gupta has received personal compensation for serving as an employee of Novartis Health Care Pvt. Ltd.
Amy Wynn, NP Ms. Wynn has nothing to disclose.
Nathaniel Michael Robbins, MD Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Vickery & Shepherd. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Vertex Pharmaceuticals . Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Neurohospitalist with Hayes Locums.
Mohamed Mohamed Belal, Jr., MD Dr. Belal has nothing to disclose.
James MacDougall, PhD Mr. MacDougall has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Actinium Pharmaceuticals. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aura Biosciences. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuro. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Catabasis Pharmaceuticals. Mr. MacDougall has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Edgewise Therapeutics. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Enterin . Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurogastrx, Inc.. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Promentis. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Synlogic Therapeutics. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cogent Biosciences. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Point Biopharma. Mr. MacDougall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx.
Saleha Azeem, MBBS Ms. Azeem has nothing to disclose.
Urvi G. Desai, MD, FAAN Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron. Dr. Desai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Muhammad M. Alvi, MD, FAAN Dr. Alvi has nothing to disclose.
Denis Eichlisberger, Other Mr. Eichlisberger has nothing to disclose.
Riadh Gouider, MD, FAAN Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Sigui Li Sigui Li has received personal compensation for serving as an employee of SAGE Therapeutics.
Karan Hingorani, MD, PhD Dr. Hingorani has nothing to disclose.
Cesar Alves CESAR ALVES has nothing to disclose.
Anas Zakarya Nourelden, Jr., MD Dr. Nourelden has nothing to disclose.
Sakinah Sabadia, MD Dr. Sabadia has nothing to disclose.
Ishah Yusaf, Other Ms. Yusaf has nothing to disclose.
Dayan Goodenowe, PhD Dr. Goodenowe has stock in Prodrome Sciences USA LLC..
Trilok Stead Trilok Stead has nothing to disclose.
Rishabh Jain, Other Mr. Jain has nothing to disclose.
Michelle Bell, MD Dr. Bell has nothing to disclose.
Lubdha Shah Lubdha Shah has nothing to disclose.
Tommy Bunte, PA Mr. Bunte has nothing to disclose.
Mihir Khunte Mr. Khunte has nothing to disclose.
Ethan Winkler, MD Dr. Winkler has nothing to disclose.
Stephanie L. Bissonnette, DO The institution of Dr. Bissonnette has received research support from Michael J Fox Foundation. The institution of Dr. Bissonnette has received research support from Cogan Family Foundation.
Sandra Mihaljevic, PhD Mrs. Mihaljevic has nothing to disclose.
Nicolas Andres Rebolledo, Sr. Dr. Rebolledo has nothing to disclose.
Mark B. Bromberg, MD, PhD, FAAN Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT Pharma. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Medical reviewer with Department of Justice, Vaccination Compensation Board.
Brian Talon, PhD Dr. Talon has nothing to disclose.
Ma Su Su Aung, MD Dr. Aung has nothing to disclose.
Ikram Sghaier Ikram Sghaier has nothing to disclose.
Sherif Reda, PhD Dr. Reda has received personal compensation for serving as an employee of Athira Pharma, Inc. . Dr. Reda has stock in Athira Pharma, Inc. .
Azizi Seixas Azizi Seixas has nothing to disclose.
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Ehad Afreen, MD Dr. Afreen has nothing to disclose.
Daniel Michael Frees Mr. Frees has nothing to disclose.
Colin Doherty, MD The institution of Dr. Doherty has received research support from UCB pharma. The institution of Dr. Doherty has received research support from Science foundation Ireland.
Mariana Delariva Sakiyama, Other Ms. Sakiyama has nothing to disclose.
Maria Gabriela Martucci, MD Dr. Martucci has nothing to disclose.
Nuriel Moghavem, MD Dr. Moghavem has nothing to disclose.
Sriramkumar Sridharan Mr. Sridharan has nothing to disclose.
Amelia Katharine Boehme, PhD Dr. Boehme has nothing to disclose.
Enmanuel Perez, MD, PhD Dr. Perez Martinez has nothing to disclose.
Kaleb H. Yohay, MD Dr. Yohay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Yohay has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Yohay has received publishing royalties from a publication relating to health care.
Robert Hemant Cascella Mr. Cascella has nothing to disclose.
Marcella A. Wozniak, MD, PhD Dr. Wozniak has nothing to disclose.
Maria Assunta Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Dragos Manta Dragos Manta has nothing to disclose.
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Vicente Alba, Other Mr. Alba has nothing to disclose.
Richard M. Tsai, MD Dr. Tsai has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Tsai has stock in Denali Therapeutics.
Susan Woolley-Levine No disclosure on file
Olga Manouvakhova, MD Dr. Manouvakhova has nothing to disclose.
Chad Schrier, RN Mr. Schrier has nothing to disclose.
John W. Day, MD, PhD Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Audentes. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Cytokinetics. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Eric Stulberg, MD Dr. Stulberg has nothing to disclose.
Roseanne Sullivan Roseanne Sullivan has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Roseanne Sullivan has stock in Novartis Pharmaceuticals.
Michel C. Shamy, MD Dr. Shamy has nothing to disclose.
Aaron Lin, MBBS Dr. Lin has nothing to disclose.
Jeremy M. Shefner, MD, PhD, FAAN Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SwanBio. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from ALS Association. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS.
Robert Hamilton, PhD Dr. Hamilton has received personal compensation for serving as an employee of NovaSignal Corp . Dr. Hamilton has received stock or an ownership interest from NovaSignal Corp. Dr. Hamilton has received intellectual property interests from a discovery or technology relating to health care.
Shima Bozorgui, MD Dr. Bozorgui has nothing to disclose.
Megan E. Lipford, PhD Dr. Lipford has nothing to disclose.
Corey M. Thibeault, PhD Dr. Thibeault has received personal compensation for serving as an employee of NovaSignal Corp.. Dr. Thibeault has received stock or an ownership interest from NovaSignal Inc..
Rana Moosavi, MD Dr. Moosavi has nothing to disclose.
Aarti Raj Katara Ms. Katara has nothing to disclose.
Anne H. Cross, MD, FAAN Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon Pharmaceuticals. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Youssef Abida, Jr., MD Mr. Abida has nothing to disclose.
Jonathan William Handshoe, MD Dr. Handshoe has nothing to disclose.
Eric Tranvinh, MD Dr. Tranvinh has nothing to disclose.
Fatemeh Sobhani, MD Dr. Sobhani has nothing to disclose.
Klaus Seppi, MD Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO . Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Seppi has received research support from MJFF. The institution of Dr. Seppi has received research support from EU. The institution of Dr. Seppi has received research support from FWF Austrian Science Fund,.
Mustafa S. Siddiqui, MD, FAAN Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. Dr. Siddiqui has received research support from Michael J. Fox Foundation. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Jose Marino Granados, MD Dr. Marino Granados has nothing to disclose.
Lara Gander, MBBS Dr. Gander has nothing to disclose.
Luella Coffey, Other Miss Coffey has nothing to disclose.
Aleena Ahmed Ms. Ahmed has nothing to disclose.
Maurizio Grassano, MD Mr. Grassano has nothing to disclose.
Maria Ait Tihyaty, PhD Dr. Ait Tihyaty has received personal compensation for serving as an employee of Janssen.
Chiara Zanetta No disclosure on file
Seung Hyun Lee, MD Dr. Lee has nothing to disclose.
Leonard H. Van den Berg, MD The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Shannon Chiu, MD Dr. Chiu has received research support from NIH/NIA.
Birendra Sah, MD Dr. Sah has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck & comp.
Mengxi Wang, PhD No disclosure on file
Kathryn Scelina Mrs. Scelina has nothing to disclose.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ischemix, Inc. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pinteon Therapeutics. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from NovaSignal . Dr. Diaz-Arrastia has received stock or an ownership interest from Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Marc Verin Mr. Verin has nothing to disclose.
Gina Dumkrieger, PhD Gina Dumkrieger has received personal compensation for serving as an employee of Mayo Clinic. The institution of Gina Dumkrieger has received research support from NIH. The institution of Gina Dumkrieger has received research support from DOD. The institution of Gina Dumkrieger has received research support from AMGEN.
Luke Heyliger, MD Dr. Heyliger has nothing to disclose.
Wondwossen G. Tekle, MD Dr. Tekle has nothing to disclose.
Laura Ferrè Laura Ferrè, 3233 has received intellectual property interests from a discovery or technology relating to health care.
Virginia DeLasHeras Virginia DeLasHeras has received personal compensation for serving as an employee of NOVARTIS.
Anson Rosenfeldt Anson Rosenfeldt has received personal compensation for serving as an employee of Cleveland Clinic. Anson Rosenfeldt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Enspire DBS. The institution of Anson Rosenfeldt has received research support from Michael J. Fox Foundation. The institution of Anson Rosenfeldt has received research support from National Institute of Health. The institution of Anson Rosenfeldt has received research support from Department of Defense. Anson Rosenfeldt has received intellectual property interests from a discovery or technology relating to health care.
Geert-Jan Groeneveld No disclosure on file
Gian D. Pal, MD Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CLRM Law. Dr. Pal has stock in Baudax Bio. The institution of Dr. Pal has received research support from National Institutes of Health. The institution of Dr. Pal has received research support from Parkinson's Foundation. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with RKV Firm.
Michael Iv, MD Dr. Iv has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience Inc. Dr. Iv has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hanalytics Pte. Ltd.. Dr. Iv has received personal compensation in the range of $0-$499 for serving as a Consultant for NordicImagingLab AS. Dr. Iv has stock in Octave Bioscience Inc..
Cynthia Zevallos Cynthia Zevallos has nothing to disclose.
Philip Arthur Bain, MD,Other Dr. Bain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thirty Madison.
Bhavya Narapureddy, MBBS Dr. Narapureddy has nothing to disclose.
Bradley Waman Clark Mr. Clark has nothing to disclose.
Isabel Lopez Mrs. Lopez has nothing to disclose.
Mohammad Ebad Ur Rehman Mr. Rehman has nothing to disclose.
Monica Eunseo Kim Miss Kim has nothing to disclose.
Yasaman Pirahanchi, MD Dr. Pirahanchi has nothing to disclose.
Jason MacMore Jason MacMore has nothing to disclose.
Rajasimhan Rajagovindan, PhD Dr. Rajagovindan has received personal compensation for serving as an employee of Biogen. Dr. Rajagovindan has received personal compensation for serving as an employee of Vigil. Dr. Rajagovindan has stock in Biogen. Dr. Rajagovindan has stock in Vigil .
Ifeyinwa Asonye, MD Dr. Nwankwo has nothing to disclose.
Kaya Gloyd Jordan, CRC Ms. Jordan has nothing to disclose.
John Zurasky, MD Dr. Zurasky has nothing to disclose.
Connor James Arrasmith Mr. Arrasmith has nothing to disclose.
María Paula Aguilera Peña, MD Dr. Aguilera Peña has nothing to disclose.
Catherine Daniela Chong, PhD, FAAN Dr. Chong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HCOP. The institution of Dr. Chong has received research support from AMGEN. The institution of Dr. Chong has received research support from Department of Defense. The institution of Dr. Chong has received research support from NIH. An immediate family member of Dr. Chong has received intellectual property interests from a discovery or technology relating to health care.
Zoe Ariel Parrales Ms. Parrales has nothing to disclose.
Sara Wesley Hyman Ms. Hyman has nothing to disclose.
Silvia Presas Silvia Presas has nothing to disclose.
Jenna Ford, MD Dr. Ford has nothing to disclose.
Rawan Albadareen, MD Dr. Albadareen has nothing to disclose.
Anoopum Gupta, MD, PhD Dr. Gupta has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biogen. The institution of Dr. Gupta has received research support from Biogen.
Maurits Vissers Mr. Vissers has received personal compensation for serving as an employee of Centre for Human Drug Research.
Carlos Alberto Campello, MD Dr. Campello has nothing to disclose.
Mohammad Nadir Haider Mr. Haider has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlinkCNS. The institution of Mr. Haider has received research support from NIH.
Lindsay Pothier Mrs. Pothier has nothing to disclose.
Pierre Trudel Mr. Trudel has nothing to disclose.
Guanhong Miao Guanhong Miao has nothing to disclose.
Matthew D. Troyer, MD Dr. Troyer has received personal compensation for serving as an employee of Denali Therapeutics Inc. Dr. Troyer has stock in Denali Therapeutics Inc. Dr. Troyer has stock in Merck & Co., Inc. Dr. Troyer has stock in Eli Lilly.
Samarah Ahmed Ms. Ahmed has nothing to disclose.
James Peterson No disclosure on file
Roxana Oana Istrate, Other Mrs. Istrate has nothing to disclose.
Wanda Castro-Borrero, MD Dr. Castro-Borrero has received personal compensation for serving as an employee of BIOGEN. Dr. Castro-Borrero has received stock or an ownership interest from BIOGEN.
Kei Sugiura, MD Dr. Sugiura has nothing to disclose.
Stephanie Carbone, RN Mrs. Carbone has nothing to disclose.
Jessica Doyle Lee, MD, FAAN Dr. Lee has received personal compensation for serving as an employee of American Academy of Neurology.
Eduardo E. Benarroch, MD, FAAN Dr. Benarroch has nothing to disclose.
Perla C. Thulin, MD Dr. Thulin has nothing to disclose.
Savanna Mahn Ms. Mahn has nothing to disclose.
Darshan Pandya, MD Dr. Pandya has nothing to disclose.
Alan Blau, PhD Dr. Blau has received personal compensation for serving as an employee of Corium, LLC.
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Blake Beehler, MD Dr. Beehler has nothing to disclose.
Wei-en Wang Dr. Wang has nothing to disclose.
Sherief Ghozy Mr. Ghozy has nothing to disclose.
Jose-Miguel Yamal The institution of Jose-Miguel Yamal has received research support from NIH/DoD.
Yun Su Hwang, MD Prof. Hwang has nothing to disclose.
Jonathan Westafer, Other Mr. Westafer has nothing to disclose.
Cristina Moglia Cristina Moglia has nothing to disclose.
Keri Feldman, Other Ms. Feldman has nothing to disclose.
Aliza Ben-Zacharia, PhD, DNP, ANP Ms. Ben-Zacharia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Theraputics. The institution of Ms. Ben-Zacharia has received research support from Biogen. The institution of Ms. Ben-Zacharia has received research support from Greenwich Biosciences.
Owen A. Ross, PhD Dr. Ross has nothing to disclose.
Cassandra Forrest, RN Mrs. Forrest has nothing to disclose.
Jodi Summers Holtrop, PhD Dr. Holtrop has nothing to disclose.
Adalia H. Jun-O'Connell, MD, MBA Dr. Jun-O'Connell has nothing to disclose.
Mary T. Silvia, MD Dr. Silvia has nothing to disclose.
Melanie Quintana No disclosure on file
Minyoul Baik, Jr., MD Dr. Baik has nothing to disclose.
Aneta Kupcova, MD Dr. Kupcova has nothing to disclose.
Felipe Condeza No disclosure on file
Jacqueline Ann Nicholas, MD Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vielo Bio. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Nicholas has received research support from Novartis. The institution of Dr. Nicholas has received research support from Biogen. The institution of Dr. Nicholas has received research support from Genentech. The institution of Dr. Nicholas has received research support from PCORI. Dr. Nicholas has a non-compensated relationship as a Physician with National MS Society that is relevant to AAN interests or activities. Dr. Nicholas has a non-compensated relationship as a Physician with Siegal Rare Neuroimmune Association that is relevant to AAN interests or activities.
Pedro De Padua Amatto Mr. Amatto has nothing to disclose.
Anek Jena, MBBS Dr. JENA has nothing to disclose.
Pranav Gandhi Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Linus Jonsson, MD,PhD Prof. Jonsson has received personal compensation for serving as an employee of H. Lundbeck A/S. The institution of Prof. Jonsson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for H. Lundbeck.
Andreas *Use 372386 Meier Andreas Meier has received personal compensation for serving as an employee of Voyager Therapeutics. Andreas Meier has received personal compensation for serving as an employee of Biogen.
Jane Boggs, MD The institution of Dr. Boggs has received research support from Liva Nova. Dr. Boggs has a non-compensated relationship as a Chairman PAB with Epilepsy Alliance North Carolina that is relevant to AAN interests or activities.
Hans J. Moebius, MD, PhD, FAAN Dr. Moebius has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Athira Pharma, Inc.. Dr. Moebius has stock in Athira Pharma, Inc..
Nadia Khalil, MD Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a Resident and Fellow Council Member with American Association of Neuromuscular & Electrodiagnostic Medicine. Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a MS Mentorship Forum Participant with Foundation of the Consortium of Multiple Sclerosis Centers.
Anthony M. Bradshaw, MD Dr. Bradshaw has nothing to disclose.
Deepti Zutshi, MD, FAAN Dr. Zutshi has nothing to disclose.
Jasmine Shareen Coles Miss Coles has nothing to disclose.
Aila Rahman Miss Rahman has nothing to disclose.
Ethan Rich No disclosure on file
Maha Daimee, MD Dr. Khan has nothing to disclose.
Marcio Souza Dr. Souza has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Souza has stock in Praxis Precision Medicines.
Corey Puryear, PhD Dr. Puryear has received personal compensation for serving as an employee of Praxis Precision Medicine. Dr. Puryear has stock in Praxis Precision Medicines.
Dharit Patel, MBBS Dr. Patel has received personal compensation for serving as an employee of Praxis Precision Medicines, Inc.. Dr. Patel has received personal compensation for serving as an employee of Noven Pharmaceuticals. Dr. Patel has stock in Praxis Precision Medicines, Inc..
Henry Claude Jacotin, MD Dr. Jacotin has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Jacotin has received personal compensation for serving as an employee of Takeda. Dr. Jacotin has stock in Takeda. Dr. Jacotin has stock in Certara. Dr. Jacotin has stock in Clover Health. Dr. Jacotin has stock in Coinbase.
Brian Pfister Dr. Pfister has received personal compensation for serving as an employee of PTC Therapeutics. Dr. Pfister has stock in PTC Therapeutics.
Olga *USE ID 201060 Thon No disclosure on file
Jesse Thon, MD An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Richa Mehta Thakkar, DO Dr. Thakkar has nothing to disclose.
Patrick McMahon, MD Dr. McMahon has nothing to disclose.
Robert John Sharkus, III, DO Dr. Sharkus has nothing to disclose.
Marie-Hélène Quesnel-Olivo, MD Dr. Quesnel-Olivo has nothing to disclose.
Donald Grosset Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Glasgow Memory Clinic. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE Healthcare. The institution of Donald Grosset has received research support from Parkinson's UK. Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Clinical Director Excellence Network with Parkinson's UK.
Ron Cohen, MD Dr. Cohen has received personal compensation for serving as an employee of Acorda Therapeutics. Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for VBL Therapeutics. Dr. Cohen has stock in Acorda Therapeutics.
Richard Marini Richard Marini has received personal compensation for serving as an employee of Acorda Therapeutics. Richard Marini has stock in Acorda Therapeutics.
Ping Zhao Ping Zhao has received personal compensation for serving as an employee of Acorda Therapeutics Inc. Ping Zhao has received stock or an ownership interest from Acorda Therapeutics Inc..
Burkhard Blank Burkhard Blank has received personal compensation for serving as an employee of Acorda Therapeutics. Burkhard Blank has received stock or an ownership interest from Acorda Therapeutics, Inc.
Bakhtawar Ahmad, MBBS Dr. Ahmad has nothing to disclose.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Bernd C. Kieseier, MD Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Emma *use 298260 Wetmore No disclosure on file
Cecilia Quarracino Benchetrit, MD Mrs. Quarracino Benchetrit has nothing to disclose.
Eric Tokita Eric Tokita has nothing to disclose.
Carlton Anderson, PhD Mr. Anderson has nothing to disclose.
Marina Ziehn, PhD No disclosure on file
Krutika Jariwala-Parikh, PhD Dr. Jariwala-Parikh has received personal compensation for serving as an employee of AbbVie. Dr. Jariwala-Parikh has stock in AbbVie.
Poojith Nuthalapati Mr. Nuthalapati has nothing to disclose.
Andreas Meier, MD Dr. Meier has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Meier has received personal compensation for serving as an employee of Voyager Therapeutics. Dr. Meier has stock in Vigil Neuroscience. Dr. Meier has stock in Voyager Therapeutics.